Osteopathies and chondropathies

M13_OSTEOCHONDRO

secondary hypertrophic osteoarthropathy: Symmetrical osteitis of the four limbs, chiefly localized to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by dorsal kyphosis and joint involvement. It is often secondary to chronic conditions of the lungs and heart. (Dorland, 27th ed)

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M80-M94, M90.6C40.99, M90.6C41.99 Cause of death: ICD-10 — M80-M94, M90.6C40.99, M90.6C41.99 2 out of 7 registries used, show all original rules.	25105
4. Check minimum number of events None	25105
5. Include endpoints M13_OSTEOPOROSIS M13_OSTEOMALACIA M13_BONECONTINUITY M13_BONEDENSOTH M13_OSTEOMYELITIS M13_OSTEONECROSIS M13_PAGET M13_OTHERBONE	27956
6. Filter based on genotype QC (FinnGen only)	27956

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	M13_OSTEOCHONDRO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_OSTEOPOROSIS\|M13_OSTEOMALACIA\|M13_BONECONTINUITY\|M13_BONEDENSOTH\|M13_OSTEOMYELITIS\|M13_OSTEONECROSIS\|M13_PAGET\|M13_OTHERBONE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M8\|M9[0-4]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M8\|M9[0-4]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Osteopathies and chondropathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	238920	147048	90558
Only index persons	211296	130432	80864
Unadjusted period prevalence (%)
Whole population	3.56	4.21	2.53
Only index persons	4.14	4.79	3.09
Median age at first event (years)
Whole population	58.16	67.68	42.65
Only index persons	55.99	65.83	40.12

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	27956	17839	10117
Unadjusted period prevalence (%)	5.49	6.08	4.46
Median age at first event (years)	57.12	59.27	53.32

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
24774: Matched controls
236502

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J01FF01

ATC

clindamycin; systemic

2.0

323.0

7141

39579

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

5.0

323.0

2958

6236

H05AA02

ATC

teriparatide; parenteral

126.5

323.0

468

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.5

323.0

9017

44510

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

323.0

3313

14261

ZXA05

NOMESCO Finland

Left side

1.9

323.0

6522

37677

M05BA07

ATC

risedronic acid; oral

6.7

323.0

1722

2609

M54.5

ICD-10 Finland

Low back pain

1.9

323.0

8336

49545

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.2

323.0

2859

9132

L95

ICPC

Osteoporosis

8.4

323.0

1753

2116

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

323.0

5432

24356

B01AB05

ATC

enoxaparin; parenteral

1.9

323.0

7794

45542

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

323.0

3642

16814

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.4

323.0

4548

14629

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

323.0

4504

22434

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.1

323.0

11312

50091

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

605.8

323.0

376

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

7.4

323.0

1213

1644

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

731.9

323.0

1031

N03AX16

ATC

pregabalin; oral

2.4

323.0

6961

33103

M93.2

ICD-10 Finland

Osteochondritis dissecans

1124.7

323.0

799

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

323.0

4293

18654

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

5.5

323.0

1230

2213

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

104.1

323.0

439

72398

ICD-8 Finland

Other diseases of bone, Alii definiti

+∞

323.0

326

M86.6

ICD-10 Finland

Other chronic osteomyelitis

1564.0

323.0

468

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

323.0

11175

69187

M05BX04

ATC

denosumab; parenteral

8.7

323.0

3031

3729

318

Kela drug reimbursment

Teriparatide

127.4

323.0

510

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.1

323.0

1408

2758

X58

ICD-10 Finland

Exposure to other specified factors

2.3

323.0

3697

16864

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

9.8

323.0

1341

1374

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

56.9

323.0

2029

370

M79.6

ICD-10 Finland

Pain in limb

1.9

323.0

9190

55377

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

477.7

323.0

826

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.6

323.0

3507

10221

M81.4

ICD-10 Finland

Drug-induced osteoporosis

81.6

323.0

387

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

323.0

7392

42470

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

112.1

323.0

2126

198

NHQ40

NOMESCO Finland

Amputation of toe

9.9

323.0

864

862

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

209.2

323.0

578

C03CA01

ATC

furosemide; systemic

2.0

323.0

7289

41008

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

323.0

9267

57633

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

17.0

323.0

1888

1142

N02BE01

ATC

paracetamol; systemic, rectal

2.5

323.0

21515

172397

M81.8

ICD-10 Finland

Other osteoporosis

26.0

323.0

598

225

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

218.7

323.0

472

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.2

323.0

1851

4500

M94.2

ICD-10 Finland

Chondromalacia

175.3

323.0

988

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

75.8

323.0

429

M81.9

ICD-10 Finland

Osteoporosis, unspecified

32.0

323.0

4195

1494

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

323.0

5378

28505

M89.0

ICD-10 Finland

Algoneurodystrophy

149.3

323.0

1135

H02AB06

ATC

prednisolone; systemic

1.8

323.0

11685

77317

M25.5

ICD-10 Finland

Pain in joint

1.9

323.0

7169

41822

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.2

323.0

2152

6897

N02AA05

ATC

oxycodone; systemic

2.9

323.0

4609

17266

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

323.0

11653

75361

L28

ICPC

Limited function/disability (L)

2.3

323.0

4410

20001

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

47.2

323.0

1242

264

M05BA04

ATC

alendronic acid; oral

6.5

323.0

4752

8294

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

517.6

323.0

1043

72221

ICD-8 Finland

Osteochondrosis, Dissecans

+∞

323.0

433

ZXA00

NOMESCO Finland

Right side

1.9

323.0

6988

40861

N02AX02

ATC

tramadol; systemic, rectal

2.3

323.0

11852

67054

N03AX12

ATC

gabapentin; oral

2.5

323.0

4615

19552

NF1AA

NOMESCO Finland

Hip X-ray examination

3.0

323.0

2791

9532

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.5

323.0

1597

2918

M84.0

ICD-10 Finland

Malunion of fracture

916.5

323.0

746

A02BC02

ATC

pantoprazole; systemic

1.8

323.0

15818

116741

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.7

323.0

1173

1742

7327A

ICD-9 Finland

Osteochondropathies, Osteochondritis dissecans[OSTEOCHONDRITIS DISSECANS GENUS]

+∞

316.9

309

SPAT1229

SPAT

Assessment of need for aid

2.7

309.2

2359

8867

S97

ICPC

Chronic ulcer skin

3.3

307.2

1668

4990

J01DB01

ATC

cefalexin; oral

1.8

307.2

19636

160942

WX320

NOMESCO Finland

Spinalanesthesy

1.9

304.8

5622

31734

M05BA06

ATC

ibandronic acid; systemic

6.1

302.8

873

1396

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

298.7

3122

13891

M86.1

ICD-10 Finland

Other acute osteomyelitis

578.1

297.5

300

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.9

293.5

1960

6772

M81.5

ICD-10 Finland

Idiopathic osteoporosis

15.3

292.0

501

318

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

290.0

9697

65782

S18

ICPC

Laceration/cut

1.7

288.2

9882

67469

A28

ICPC

Limited function/disability NOS

2.1

283.7

3770

18668

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.1

283.1

955

1843

AA1AD

NOMESCO Finland

CT of head and brain

1.8

276.3

5706

33308

A46

ICD-10 Finland

Erysipelas

2.1

275.6

3514

17078

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

252.5

275.2

287

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

274.8

3415

16410

M85.8

ICD-10 Finland

Other specified disorders of bone density and structure

90.8

273.3

310

J01MA02

ATC

ciprofloxacin; systemic

1.7

271.8

9059

61063

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

269.4

5508

32002

J01MA12

ATC

levofloxacin; systemic

1.9

263.1

4479

24373

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

260.1

6947

43818

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

259.7

2587

11187

N06AX21

ATC

duloxetine; oral

2.2

255.9

2805

12701

M80

ICD-10 Finland

Osteoporosis with pathological fracture

13.2

254.6

465

342

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

253.2

2723

12213

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

249.8

2757

12515

M92.5

ICD-10 Finland

Juvenile osteochondrosis of tibia and fibula

88.5

249.6

284

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

247.7

2869

13311

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

5.8

243.1

733

1238

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

242.7

8277

55662

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.7

242.6

1781

6501

SPAT1254

SPAT

Administration of medicine

2.0

242.4

3764

19719

R4110

NOMESCO Finland

Physiotherapy

1.7

241.9

6330

39509

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

239.4

3732

19573

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.7

238.5

1832

6868

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.6

237.1

1930

7480

A06AD11

ATC

lactulose; oral

2.0

237.1

3551

18331

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

236.3

3878

20726

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.3

234.8

2463

10894

L17

ICPC

Foot/toe symptom/complaint

1.7

232.0

5969

36988

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

231.2

6315

39814

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.9

228.4

1534

5290

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.4

227.4

880

1956

SPAT1216

SPAT

Assessment of functional ability

1.9

224.7

3741

20058

M86.8

ICD-10 Finland

Other osteomyelitis

435.3

223.1

227

L03

ICPC

Low back symptom/complaint

1.7

222.0

5634

34692

R06.0

ICD-10 Finland

Dyspnoea

1.7

219.6

5769

35864

W19

ICD-10 Finland

Unspecified fall

2.2

218.8

2438

11071

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

215.6

5029

30142

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.5

214.8

1830

7259

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.2

210.7

1211

3752

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

210.6

2717

13151

ZX120

NOMESCO Finland

Intravenous

2.2

210.1

2395

10981

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

209.2

3934

21961

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.5

206.3

773

1663

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.7

205.6

1536

5647

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

203.5

2088

9104

M01AH05

ATC

etoricoxib; oral

1.5

202.2

13195

102012

M48.0

ICD-10 Finland

Spinal stenosis

2.0

201.5

2891

14594

P01BA02

ATC

hydroxychloroquine; oral

2.3

201.5

2166

9655

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.8

201.5

1386

4842

NF3AA

NOMESCO Finland

Femur X-ray examination

5.0

200.4

681

1321

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

200.2

2200

9904

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.3

196.0

2045

8980

A02BC05

ATC

esomeprazole; systemic

1.5

195.1

9204

66026

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

194.8

1928

8251

S52.5

ICD-10 Finland

Fracture of lower end of radius

2.1

194.8

2505

12082

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

194.7

3428

18658

WX002

NOMESCO Finland

Sedation and analgesia

1.7

194.3

4608

27637

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

193.9

7530

51581

N06AX11

ATC

mirtazapine; oral

1.6

189.9

7184

48839

N06AA09

ATC

amitriptyline; systemic

2.1

189.8

2525

12343

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.0

189.7

2631

13081

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.2

189.6

1060

3215

M86.4

ICD-10 Finland

Chronic osteomyelitis with draining sinus

1710.5

189.3

187

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

189.0

1843

7826

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.9

188.9

660

1319

R50.9

ICD-10 Finland

Fever, unspecified

1.9

188.1

3238

17466

UJF32

NOMESCO Finland

Coloscopy

1.6

187.7

5820

37594

R60.0

ICD-10 Finland

Localized oedema

2.0

186.3

2649

13296

N05CF01

ATC

zopiclone; oral

1.6

186.0

7378

50678

L04AX01

ATC

azathioprine; systemic

2.9

185.6

1220

4136

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.7

183.8

1354

4927

M84.2

ICD-10 Finland

Delayed union of fracture

145.0

181.2

196

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

180.8

1595

6427

M92.6

ICD-10 Finland

Juvenile osteochondrosis of tarsus

155.5

180.3

194

A02BC01

ATC

omeprazole; systemic

1.6

178.9

6323

42141

H02AB07

ATC

prednisone; oral

1.8

178.3

3383

18843

M05BX03

ATC

strontium ranelate; oral

10.7

178.1

359

325

A02BC03

ATC

lansoprazole; oral

1.6

177.1

6645

44918

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

176.6

4076

24158

S72.0

ICD-10 Finland

Fracture of neck of femur

3.1

176.5

1060

3379

SPAT1153

SPAT

Removal of sutures

1.5

176.2

7152

49243

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

4.8

175.0

617

1245

SPAT1263

SPAT

Sampling

1.5

174.7

9657

71174

L76

ICPC

Fracture: other

3.6

174.2

836

2251

H02AB04

ATC

methylprednisolone; systemic

1.8

172.2

3410

19244

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

171.8

2955

15894

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

7.4

171.2

430

566

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

170.0

1424

5575

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.1

169.7

708

1687

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

168.9

2941

15880

J01DA01

ATC

[U] cefalexin; systemic

1.5

167.9

14242

114099

R51.80

ICD-10 Finland

Headache

1.8

167.8

3318

18701

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

167.4

6491

44095

R53

ICD-10 Finland

Malaise and fatigue

1.6

165.7

4636

28973

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.3

165.1

532

971

WX212

NOMESCO Finland

Femoral plexus blockade

4.4

164.9

638

1415

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

164.6

1662

7158

M85.4

ICD-10 Finland

Solitary bone cyst

167.2

162.7

174

R03AC02

ATC

salbutamol; inhalant

1.4

162.5

11733

90804

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

7.7

161.6

393

493

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

160.8

5940

39814

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.8

160.2

1136

4033

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.4

159.9

610

1334

SPAT1301

SPAT

No procedures

1.5

158.8

7162

50236

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

158.0

2225

11084

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

157.0

2883

15822

A01

ICPC

Pain general/multiple sites

2.1

156.5

1877

8745

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

156.3

9278

68882

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.6

154.7

1222

4623

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

12.1

154.7

293

234

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.5

154.5

1310

5153

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

153.1

4648

29604

C07AB07

ATC

bisoprolol; oral

1.4

152.3

10162

77075

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

151.2

3171

18160

M02AA07

ATC

piroxicam; topical

1.5

150.9

8202

59690

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

150.6

8337

60892

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

149.7

11237

87060

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

149.7

3223

18604

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

149.1

3591

21440

WX213

NOMESCO Finland

Lower leg blockade

8.6

148.8

338

380

M93.1

ICD-10 Finland

Kienböck disease of adults

714.1

148.6

149

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.3

148.4

813

2424

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.0

148.1

943

3122

WX110

NOMESCO Finland

Local anesthesy

1.4

148.0

15369

126373

L13

ICPC

Hip symptom/complaint

1.7

147.3

3523

20981

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.2

147.0

588

1346

NH1AD

NOMESCO Finland

Ankle and foot CT

3.9

146.1

640

1593

9102

FHL

Trepanation or removal of the local bone process

8.5

146.0

333

377

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

143.5

3864

23784

S72.1

ICD-10 Finland

Pertrochanteric fracture

4.0

143.4

620

1525

M86.0

ICD-10 Finland

Acute haematogenous osteomyelitis

+∞

143.4

140

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.7

142.0

1040

3761

ZZA00

NOMESCO Finland

Split skin graft

3.2

141.9

801

2441

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.7

141.7

1030

3709

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

141.2

2202

11379

R4120

NOMESCO Finland

Occupational therapy

2.2

141.1

1515

6705

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

3.7

140.7

653

1708

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

140.2

3875

24000

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

140.0

1689

7873

SPAT1255

SPAT

Intravenous administration of medicine

2.2

139.2

1548

6959

S22.3

ICD-10 Finland

Fracture of rib

2.2

139.2

1483

6539

E0000UV

ATC

1.4

138.2

8633

64265

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.3

137.7

1372

5856

M87.3

ICD-10 Finland

Other secondary osteonecrosis

660.9

137.4

138

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

137.4

4060

25583

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.5

137.0

1185

4708

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

136.8

1695

7992

G56.4

ICD-10 Finland

Causalgia

13.0

136.7

250

185

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.0

136.4

579

1401

L04AA06

ATC

mycophenolic acid; systemic

4.3

135.7

540

1230

M01AC06

ATC

meloxicam; systemic, rectal

1.4

134.7

8017

59046

L88

ICPC

Rheumatoid/seropositive arthritis

2.7

134.5

994

3611

M84.8

ICD-10 Finland

Other disorders of continuity of bone

101.5

132.4

148

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

4.9

132.4

462

922

M03BX02

ATC

tizanidine; oral

1.4

132.3

13510

109580

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.1

131.7

775

2432

5BA08

NOMESCO Finland

10.4

131.6

268

248

M01AE02

ATC

naproxen; oral, rectal

1.4

131.3

12532

100400

M01AH02

ATC

rofecoxib; oral

1.7

130.7

3005

17634

SPAT1211

SPAT

Application of soft bandage

1.9

130.5

2110

11033

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.0

130.3

817

2677

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

4.7

129.9

471

978

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

129.3

6078

42601

A07EC01

ATC

sulfasalazine; oral, rectal

2.0

129.1

1869

9375

127

Kela drug reimbursment

Transplant complication

4.5

128.9

482

1033

M93.9

ICD-10 Finland

Osteochondropathy, unspecified

134.4

128.7

140

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.8

128.6

909

3215

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

128.6

1163

4727

M89.9

ICD-10 Finland

Disorder of bone, unspecified

87.7

128.5

146

72299

ICD-8 Finland

Unspecified forms of osteochondrosis

+∞

128.0

125

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

127.2

3538

21889

J01AA02

ATC

doxycycline; systemic

1.4

126.8

17604

150088

R03BB04

ATC

tiotropium bromide; inhalant

1.9

126.4

2070

10867

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

125.9

2361

12987

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.6

125.9

613

1668

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.6

125.5

595

1584

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

125.1

3039

18105

NCK30

NOMESCO Finland

Angulation, rotation or displacement osteotomy of elbow or forearm, other location

19.2

125.0

196

M13.9

ICD-10 Finland

Arthritis, unspecified

2.1

124.5

1619

7777

N05BA04

ATC

oxazepam; oral

1.5

123.8

5348

36754

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

123.8

4182

27171

M83.2

ICD-10 Finland

Adult osteomalacia due to malabsorption

400.8

123.6

126

L16

ICPC

Ankle symptom/complaint

1.8

123.4

2256

12299

L04AA13

ATC

leflunomide; oral

3.1

122.9

711

2204

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

122.5

1332

5917

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

122.4

1675

8212

R52.2

ICD-10 Finland

Other chronic pain

2.8

121.7

849

2976

J01MA14

ATC

moxifloxacin; systemic

1.9

121.6

1939

10076

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

121.6

1944

10112

M01AB05

ATC

diclofenac; systemic, rectal

1.4

121.1

14652

121385

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

120.7

1758

8830

J01EA01

ATC

trimethoprim; systemic

1.5

120.6

5629

39290

M86.2

ICD-10 Finland

Subacute osteomyelitis

391.2

120.6

123

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.9

120.6

1870

9617

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.2

120.2

481

1102

L15

ICPC

Knee symptom/complaint

1.5

120.1

4508

29997

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

119.6

4459

29619

J01FA06

ATC

roxithromycin; oral

1.4

119.6

8747

66504

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

119.0

1497

7087

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.8

118.9

2461

13956

A02BA02

ATC

ranitidine; systemic

1.5

118.8

4286

28244

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

118.6

8890

67855

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

4.0

118.5

505

1226

R52.9

ICD-10 Finland

Pain, unspecified

1.9

118.0

1869

9681

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.6

118.0

946

3598

H02AB09

ATC

hydrocortisone; systemic

3.3

117.5

630

1847

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

117.3

3467

21748

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.4

117.3

604

1717

L04AA01

ATC

[U] ciclosporin; systemic

4.2

117.3

470

1078

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

117.1

1538

7411

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.9

117.0

513

1278

N30.0

ICD-10 Finland

Acute cystitis

1.6

116.8

3087

18797

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

116.8

4384

29147

R11

ICD-10 Finland

Nausea and vomiting

1.9

116.8

1813

9324

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.8

116.2

525

1342

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

115.2

1909

10050

M94.9

ICD-10 Finland

Disorder of cartilage, unspecified

43.5

114.7

145

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.9

113.3

752

2554

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

113.2

1008

4060

N06AX16

ATC

venlafaxine; oral

1.7

113.1

2859

17183

P01AB01

ATC

metronidazole; oral, rectal

1.4

112.8

8404

63912

M01AX17

ATC

nimesulide; oral

1.5

112.7

5282

36811

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.7

112.6

827

2990

R42

ICD-10 Finland

Dizziness and giddiness

1.5

112.5

4643

31497

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

112.5

6675

48723

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

112.4

2172

12039

M92.7

ICD-10 Finland

Juvenile osteochondrosis of metatarsus

145.1

112.1

121

TK800

NOMESCO Finland

Hemodialysis

3.5

111.7

563

1574

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

111.6

4431

29794

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

111.0

4813

32983

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

110.6

2519

14687

WZA90

NOMESCO Finland

Other doctors statement

1.5

110.6

4868

33466

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.6

110.3

881

3342

B01AA03

ATC

warfarin; systemic

1.5

109.7

3987

26267

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

109.3

1678

8584

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

109.3

1514

7447

N05AH04

ATC

quetiapine; oral

1.6

109.2

3332

21035

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.9

108.9

473

1168

M91.1

ICD-10 Finland

Juvenile osteochondrosis of head of femur [Legg-Calvé-Perthes]

352.4

108.4

111

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

9.5

108.0

230

232

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.6

108.0

819

3019

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.2

107.9

610

1860

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.6

106.8

814

3006

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.7

106.6

283

405

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

106.5

1715

8923

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

3.6

106.4

512

1380

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

106.3

1216

5521

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

105.5

2895

17771

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

105.3

2648

15871

M85.9

ICD-10 Finland

Disorder of bone density and structure, unspecified

82.3

104.9

120

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.9

104.4

1633

8408

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.4

103.9

541

1551

R06AE07

ATC

cetirizine; oral

1.4

103.2

9345

73083

A11CC03

ATC

alfacalcidol; systemic

3.1

102.8

591

1823

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

4.9

102.8

353

693

M05BA01

ATC

etidronic acid; systemic

7.2

102.5

259

345

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

102.5

701

2425

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

102.5

1086

4762

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

102.4

2788

17065

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

102.0

4778

33187

J04AB02

ATC

rifampicin; systemic

4.6

101.7

374

789

M87.8

ICD-10 Finland

Other osteonecrosis

967.0

101.4

101

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.9

101.3

1509

7627

SPAT1234

SPAT

Support of social functional capacity

2.2

101.2

1143

5159

JN4BD

NOMESCO Finland

Extensive body CT

1.7

101.1

2274

13188

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

101.0

2172

12428

L11

ICPC

Wrist symptom/complaint

1.9

101.0

1690

8909

1220

FHL

Arthroscopy

2.4

100.8

935

3841

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

100.7

1019

4369

H3603, E103

ICD-10 Finland

5.2

100.4

330

617

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

100.4

1738

9272

M16.7

ICD-10 Finland

Other secondary coxarthrosis

6.1

100.3

287

454

C08CA01

ATC

amlodipine; oral

1.4

100.3

7300

54995

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

100.3

814

3117

S72.3

ICD-10 Finland

Fracture of shaft of femur

5.4

99.9

313

554

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

99.6

1018

4387

72399

ICD-8 Finland

Other diseases of bone

+∞

99.3

72222

ICD-8 Finland

Osteochondrosis, Tuberositatis tibiae (Schlatter)

+∞

99.3

A07AA02

ATC

nystatin; oral

2.0

99.2

1426

7109

ZXA10

NOMESCO Finland

Bilateral

1.5

99.1

3974

26691

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

98.7

1535

7881

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.6

98.4

473

1274

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

98.3

8076

62025

72209

ICD-8 Finland

Osteochondrosis, spinalis juvenilis (Scheuermann) NUD

+∞

98.3

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.7

98.1

735

2688

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

6.4

98.0

269

403

SPAT1260

SPAT

Consultation of another employee

1.5

97.8

3793

25281

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

97.6

1567

8137

N05BA01

ATC

diazepam; systemic, rectal

1.6

97.4

2836

17650

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.8

97.3

675

2356

A04

ICPC

Weakness/tiredness general

1.6

97.2

2739

16900

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.9

96.6

1440

7277

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

96.4

1589

8328

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

96.2

12165

99711

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

95.9

5073

36027

NH3CG

NOMESCO Finland

Extensive MRI of foot

7.8

95.3

228

280

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.8

95.3

646

2224

7324B

ICD-9 Finland

Osteochondropathies, Juvenile osteochondrosis of lower extremity, excluding foot[OSTEOCHONDROSIS JUVENILIS TUBEROSITATIS TIBIAE]

+∞

95.2

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

94.8

884

3639

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.4

94.6

824

3276

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

94.6

4281

29466

WZC30

NOMESCO Finland

Teaching

1.6

94.2

2686

16618

NGU20

NOMESCO Finland

Removal of internal fixation device from knee or lower leg

3.5

93.7

462

1270

M93.8

ICD-10 Finland

Other specified osteochondropathies

189.7

93.6

C03DA01

ATC

spironolactone; oral

1.7

93.3

2175

12727

L12

ICPC

Hand/finger symptom/complaint

1.6

93.3

2926

18537

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

890.0

93.3

L02

ICPC

Back symptom/complaint

1.8

92.6

1875

10517

N06AB04

ATC

citalopram; systemic

1.4

92.3

4472

31187

W10

ICD-10 Finland

Fall on and from stairs and steps

2.1

92.3

1096

5054

J01CA08

ATC

pivmecillinam; oral

1.3

92.2

8644

67593

7339X

ICD-9 Finland

Other disorders of bone and cartilage, Other and unspecified disorders of bone and cartilage

+∞

92.1

A10AE04

ATC

insulin glargine; parenteral

1.7

92.1

1898

10705

M89.3

ICD-10 Finland

Hypertrophy of bone

108.6

92.1

102

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

92.0

802

3192

L84

ICD-10 Finland

Corns and callosities

2.5

91.9

773

3018

SPAT1262

SPAT

Handing over of treatment supplies

1.5

91.8

3682

24683

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

91.6

1483

7717

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

91.3

1782

9879

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

91.0

1093

5063

J01CA04

ATC

amoxicillin; systemic

1.3

90.8

18198

158942

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

90.8

987

4376

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.1

90.6

539

1701

L04AD01

ATC

ciclosporin; systemic

3.3

90.5

489

1442

E21.0

ICD-10 Finland

Primary hyperparathyroidism

3.8

90.5

407

1037

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

90.4

5088

36492

M88.9

ICD-10 Finland

Paget disease of bone, unspecified

+∞

90.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

90.0

2457

15012

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

89.8

826

3379

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

89.5

890

3783

S72.4

ICD-10 Finland

Fracture of lower end of femur

5.6

89.0

273

472

Z71.8

ICD-10 Finland

Other specified counselling

1.4

88.2

4814

34307

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.5

88.2

764

3028

S06.0

ICD-10 Finland

Concussion

1.7

88.1

2146

12709

72000

ICD-8 Finland

Osteomyelitis and periostitis, Acute osteomyelitis

+∞

88.0

7327X

ICD-9 Finland

Osteochondropathies, Osteochondritis dissecans[OSTEOCHONDRITIS DISSECANS ALIA LOCO DEFINITO]

+∞

88.0

N05CD07

ATC

temazepam; oral

1.6

88.0

2620

16366

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

88.0

7168

54727

Z04.3

ICD-10 Finland

Examination and observation following other accident

3.0

87.9

540

1744

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

87.9

750

2948

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

87.8

1128

5370

J02AC01

ATC

fluconazole; systemic

1.3

87.7

8262

64507

L08

ICPC

Shoulder symptom/complaint

1.5

87.6

3820

26043

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

87.4

4370

30618

M02AA10

ATC

ketoprofen; topical

1.5

87.4

3322

21988

72288

ICD-8 Finland

Other specified forms of osteochondrosis

+∞

87.0

S70.0

ICD-10 Finland

Contusion of hip

2.4

86.7

788

3203

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

86.7

8349

65371

NH3BG

NOMESCO Finland

MRI of foot

6.8

86.5

227

320

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

86.5

580

1981

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.7

86.3

617

2193

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.0

86.2

524

1680

M01CB01

ATC

sodium aurothiomalate; parenteral

3.6

86.1

419

1140

G44.2

ICD-10 Finland

Tension-type headache

1.6

86.0

2671

16856

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

85.9

2322

14143

M87.2

ICD-10 Finland

Osteonecrosis due to previous trauma

215.5

85.8

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.1

85.5

498

1550

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

5.4

85.5

270

483

WX204

NOMESCO Finland

Axillary plexus blockaced

2.5

85.4

713

2772

M77.4

ICD-10 Finland

Metatarsalgia

2.0

85.2

1145

5552

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.2

85.1

279

521

R02

ICPC

Shortness of breath/dyspnoea

1.6

84.8

2448

15165

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

84.4

13707

115398

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

84.4

2069

12266

Z94.0

ICD-10 Finland

Kidney transplant status

4.4

84.1

324

717

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

83.8

2356

14491

L75

ICPC

Fracture: femur

4.1

83.8

341

795

Z50.1

ICD-10 Finland

Other physical therapy

2.0

83.8

1189

5891

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

83.6

1243

6269

NGQ20

NOMESCO Finland

Amputation of lower leg

7.6

83.5

203

256

WX892

NOMESCO Finland

Monitored bed care

1.8

83.4

1527

8280

M22.4

ICD-10 Finland

Chondromalacia patellae

2.5

83.4

691

2675

M85.6

ICD-10 Finland

Other cyst of bone

82.8

83.3

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

83.2

1745

9884

I50.0

ICD-10 Finland

Congestive heart failure

1.9

83.1

1379

7235

R07.3

ICD-10 Finland

Other chest pain

1.7

82.7

1933

11301

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

82.7

1584

8719

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.9

82.5

359

889

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

6.3

82.3

229

350

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.3

82.1

802

3379

R4180

NOMESCO Finland

Podiatric therapy

4.6

82.0

300

631

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

81.9

3322

22271

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

81.8

1989

11757

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

81.8

2509

15771

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.0

81.7

495

1582

A12AA04

ATC

calcium carbonate; oral

3.5

81.7

407

1129

J01CF05

ATC

flucloxacillin; systemic

2.3

81.2

815

3479

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.8

81.1

555

1923

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.7

81.1

575

2036

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

80.6

620

2301

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

80.4

11480

94686

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

80.4

2105

12699

M54

ICD-10 Finland

Dorsalgia

1.6

80.2

2233

13691

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.4

80.2

416

1191

M94.8

ICD-10 Finland

Other specified disorders of cartilage

47.4

79.8

D07AC01

ATC

betamethasone; topical

1.3

79.8

6909

53062

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.6

79.6

598

2192

M79.1

ICD-10 Finland

Myalgia

1.6

79.4

2547

16175

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

79.3

3496

23828

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

79.0

3392

22994

K02.1

ICD-10 Finland

Caries of dentine

1.3

79.0

11801

97834

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.0

78.9

1148

5739

NHF25

NOMESCO Finland

Operation for debridement of ankle joint, arthroscopic

4.6

78.5

286

599

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

78.4

15105

129450

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

78.0

1306

6867

N03AE01

ATC

clonazepam; systemic

1.9

77.9

1208

6183

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.8

77.8

353

907

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

77.6

777

3312

S72.2

ICD-10 Finland

Subtrochanteric fracture

5.4

77.6

245

439

NF1DA

NOMESCO Finland

X-ray of hips

2.7

77.4

546

1927

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

18.1

77.3

123

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

77.2

1000

4777

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

77.0

1266

6616

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

5.2

76.9

248

455

R03DC03

ATC

montelukast; oral

1.5

76.9

3182

21395

B01AB10

ATC

tinzaparin; parenteral

1.8

76.9

1412

7662

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

76.9

899

4112

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

76.9

8656

68974

UKC02

NOMESCO Finland

Cystoscopy

1.5

76.8

2947

19496

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.8

76.6

523

1809

V03AE01

ATC

polystyrene sulfonate; oral

4.1

76.1

316

751

SPAT1210

SPAT

Application of cast or individual aid

2.1

76.0

940

4404

M88.88

ICD-10 Finland

Paget disease of other bones, other

+∞

75.7

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.6

75.7

356

943

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

75.7

5482

40866

ZZH31

NOMESCO Finland

Bone allograft, small pieces

4.8

75.6

262

521

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

75.5

1927

11535

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.6

75.3

566

2071

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

75.3

2526

16203

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

75.0

872

3979

NGF40

NOMESCO Finland

Repair of defect of cartilage in the knee joint with transplant

14.5

75.0

130

M81

ICD-10 Finland

Osteoporosis without pathological fracture

6.1

74.9

212

332

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.5

74.8

645

2550

7328A

ICD-9 Finland

Osteochondropathies, Other specified forms of osteochondropathy[JALKATERÄN YLIMÄÄRÄISTEN LUIDEN AIHEUTTAMAT OIREET]

+∞

74.7

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

5.3

74.7

237

427

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

74.6

1609

9179

9254

FHL

Arthrotomy (includes biopsy, revision, loose removal, fixation, and similar procedures)

5.1

74.5

247

468

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

74.5

707

2937

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

74.4

20410

183061

J46

ICD-10 Finland

Status asthmaticus

2.5

74.1

630

2470

M85.0

ICD-10 Finland

Fibrous dysplasia (monostotic)

707.2

73.9

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

4.3

73.7

284

629

A01AB09

ATC

miconazole; local oral

1.6

73.7

1868

11156

7328B

ICD-9 Finland

Osteochondropathies, Other specified forms of osteochondropathy[MUIDEN YLIMÄÄRÄISTEN LUIDEN AIHEUTTAMAT OIREET]

+∞

73.7

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

73.6

1905

11442

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.5

73.6

606

2338

A10AA02

ATC

2.3

73.5

736

3137

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

73.5

1222

6410

B03XA02

ATC

darbepoetin alfa; parenteral

3.1

73.4

422

1303

T92.2

ICD-10 Finland

Sequelae of fracture at wrist and hand level

4.9

73.4

250

488

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.3

73.2

698

2903

R03BA05

ATC

fluticasone; inhalant

1.4

73.2

3646

25420

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.4

72.9

373

1057

Z00.0

ICD-10 Finland

General medical examination

1.4

72.5

3689

25820

J01XX08

ATC

linezolid; systemic

6.9

72.5

189

265

T93.2

ICD-10 Finland

Sequelae of other fractures of lower limb

4.1

72.1

295

692

C90.0

ICD-10 Finland

Multiple myeloma

4.1

72.0

297

702

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

71.9

978

4762

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

71.6

1864

11212

M01AB55

ATC

diclofenac, combinations; oral

1.7

71.4

1458

8180

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

71.3

1349

7386

NFB60

NOMESCO Finland

Demanding prosthetic replacement of hip

7.1

70.9

180

243

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.4

70.9

641

2599

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.7

70.8

506

1800

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

70.8

9931

81196

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

70.8

1838

11047

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

70.7

1638

9539

N02AC04

ATC

dextropropoxyphene; oral

2.1

70.7

810

3674

M19.2

ICD-10 Finland

Other secondary arthrosis

3.6

70.6

334

890

SPAT1310

SPAT

Counselling related to known health issue

1.3

70.6

6574

50831

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

70.5

913

4357

A10AA01

ATC

2.5

70.3

581

2245

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

3.4

70.3

359

1016

N03AX09

ATC

lamotrigine; oral

2.0

70.2

916

4386

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

70.1

10990

91095

M01AX05

ATC

glucosamine; oral

1.4

69.8

4153

29880

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

69.8

1077

5499

NDJ86

NOMESCO Finland

Late fixation of fracture of hand or wrist to promote bone formation

17.6

69.7

112

R52.1

ICD-10 Finland

Chronic intractable pain

4.6

69.6

253

529

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.4

69.6

623

2511

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.7

69.2

245

499

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

69.2

5486

41383

L29

ICPC

Musculoskeletal sympt/complt other

1.7

69.1

1497

8545

K59.0

ICD-10 Finland

Constipation

1.9

69.1

1137

5938

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.2

68.8

383

1156

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

6.7

68.8

183

264

M81.1

ICD-10 Finland

Postoophorectomy osteoporosis

174.7

68.8

S82.2

ICD-10 Finland

Fracture of shaft of tibia

3.2

68.7

386

1173

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.0

68.7

289

696

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

68.6

2654

17554

M43.1

ICD-10 Finland

Spondylolisthesis

2.1

68.5

822

3802

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

68.4

477

1672

L86

ICPC

Back syndrome with radiating pain

1.9

68.2

1132

5932

JN4AD

NOMESCO Finland

Body CT examination

1.7

68.2

1452

8246

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.1

68.1

808

3719

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

68.1

853

4017

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.2

68.0

742

3292

T89

ICPC

Diabetes insulin dependent

2.1

68.0

778

3524

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

68.0

5362

40396

S29

ICPC

Skin symptom/complaint other

1.4

67.8

3297

22843

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

67.8

1211

6507

N18.8

ICD-10 Finland

Other chronic renal failure

2.5

67.7

564

2190

R03AC12

ATC

salmeterol; inhalant

2.0

67.6

926

4517

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

67.5

687

2950

NDG30

NOMESCO Finland

Fusion of wrist, total

6.1

67.5

192

303

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

5.1

67.3

223

423

S80.0

ICD-10 Finland

Contusion of knee

1.8

67.2

1289

7086

L14

ICPC

Leg/thigh symptom/complaint

1.7

67.1

1489

8558

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.6

67.0

504

1846

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

67.0

1424

8079

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.3

66.9

361

1066

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

66.8

4157

30121

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

2.1

66.7

795

3666

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.1

66.6

761

3444

B01AC04

ATC

clopidogrel; oral

1.5

66.6

2832

19100

M84.9

ICD-10 Finland

Disorder of continuity of bone, unspecified

137.8

66.6

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

66.3

4312

31470

SPAT1325

SPAT

Vaccination

1.3

66.3

7042

55358

S42.0

ICD-10 Finland

Fracture of clavicle

2.4

66.1

594

2400

NHS20

NOMESCO Finland

Incision and debridement of infection of bone of ankle or foot

58.2

66.1

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

9.3

66.1

142

147

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

5.4

66.0

206

365

R13

ICD-10 Finland

Dysphagia

1.8

66.0

1248

6831

M04AA01

ATC

allopurinol; systemic

1.5

65.9

2318

15003

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.5

65.8

556

2176

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

65.8

4767

35406

NGK05

NOMESCO Finland

Partial or total excision of bone of lower leg

29.7

65.7

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

65.6

3860

27688

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

65.5

906

4439

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

11.5

65.2

125

104

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

65.0

1007

5147

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.7

64.9

472

1695

A29

ICPC

General symptom/complaint other

1.5

64.9

2155

13763

Z01.2

ICD-10 Finland

Dental examination

1.3

64.8

8333

67130

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

64.8

5567

42432

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.4

64.8

245

534

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

64.7

1188

6437

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.7

64.6

299

783

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.2

64.5

661

2848

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

64.5

1393

7940

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

64.4

671

2914

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.2

64.4

359

1086

ZZH40

NOMESCO Finland

Substitute of bone

3.9

64.3

274

668

NBJ62

NOMESCO Finland

Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus

3.4

64.2

328

929

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

64.2

3402

23937

H26.4

ICD-10 Finland

After-cataract

1.6

64.1

1795

10990

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

64.1

966

4888

S82.1

ICD-10 Finland

Fracture of upper end of tibia

2.9

64.0

405

1335

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

11.4

64.0

123

103

EBA00

NOMESCO Finland

Extraction of tooth

1.3

63.9

6496

50696

NDA30

NOMESCO Finland

Exploration of joint of wrist or hand, arthroscopic

4.4

63.9

241

524

A07AA09

ATC

vancomycin; oral

3.5

63.7

313

860

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

63.7

1138

6113

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.2

63.6

350

1049

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.4

63.4

242

532

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.8

63.4

443

1554

NGJ86

NOMESCO Finland

Late operation of fracture of lower leg to promote bone formation

18.4

63.4

100

R03BA01

ATC

beclometasone; inhalant

1.5

63.2

2774

18820

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

62.9

794

3749

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

62.8

3939

28539

S42.3

ICD-10 Finland

Fracture of shaft of humerus

3.5

62.8

306

836

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

62.5

1241

6895

NDG20

NOMESCO Finland

Fusion of wrist, partial

5.8

62.4

185

308

72211

ICD-8 Finland

Osteochondrosis, Coxae planae

+∞

62.4

R33

ICD-10 Finland

Retention of urine

1.7

62.3

1281

7194

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

62.2

1892

11825

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

62.2

2027

12882

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.8

62.2

413

1403

B01AF01

ATC

rivaroxaban; oral

1.5

62.0

2225

14454

SPAT1312

SPAT

General health counselling

1.3

61.9

6541

51264

R55

ICD-10 Finland

Syncope and collapse

1.5

61.9

2063

13180

9165

FHL

Removal of osteosynthesis material

2.6

61.8

466

1713

M94.1

ICD-10 Finland

Relapsing polychondritis

128.2

61.6

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.6

61.6

221

457

NA2AD

NOMESCO Finland

Thoracic spine CT examination

5.7

61.5

184

310

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

61.5

840

4095

7330A

ICD-9 Finland

Other disorders of bone and cartilage, Osteoporosis[OSTEOPOROSIS CENTRALIS]

+∞

61.4

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.5

61.3

500

1917

J01CF02

ATC

cloxacillin; systemic

2.5

61.3

504

1943

M79.7

ICD-10 Finland

Fibromyalgia

2.2

61.3

660

2911

ECB20

NOMESCO Finland

Oral alveoplasty

4.2

61.2

246

569

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.9

61.1

900

4516

M23.8

ICD-10 Finland

Other internal derangements of knee

2.1

61.1

725

3335

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

3.3

60.9

319

922

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

60.8

1120

6074

R52.0

ICD-10 Finland

Acute pain

2.2

60.7

619

2663

A10AE05

ATC

insulin detemir; parenteral

1.8

60.6

1076

5762

M93.0

ICD-10 Finland

Slipped upper femoral epiphysis (nontraumatic)

+∞

60.4

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.3

60.4

327

969

M80.1

ICD-10 Finland

Postoophorectomy osteoporosis with pathological fracture

299.3

60.2

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

60.1

1493

8850

SPAT1172

SPAT

Guidance concerning hydration

2.5

60.1

502

1950

NGF30

NOMESCO Finland

Fixation of loose body of joint of knee

14.4

60.1

104

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

59.9

578

2419

B01AB04

ATC

dalteparin; parenteral

1.9

59.9

992

5191

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

3.5

59.8

298

829

R03BA02

ATC

budesonide; inhalant

1.4

59.7

3440

24536

WX290

NOMESCO Finland

Other blockade of nerve

1.3

59.7

8603

70086

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.4

59.5

551

2261

WX402

NOMESCO Finland

General anaesthesia

1.4

59.4

3135

22008

NG1AD

NOMESCO Finland

Knee CT examination

3.2

59.4

323

960

72029

ICD-8 Finland

Osteomyelitis and periostitis, Unspecified ostemyelitis

+∞

59.4

NBJ86

NOMESCO Finland

Late operation of shoulder or upper arm to promote bone formation

21.3

59.2

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

59.1

1542

9266

S20.2

ICD-10 Finland

Contusion of thorax

1.9

59.0

915

4678

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

58.8

1470

8731

RF210

NOMESCO Finland

2.3

58.6

594

2548

E000001

ATC

1.4

58.6

4029

29601

H25.8

ICD-10 Finland

Other senile cataract

1.5

58.5

2030

13080

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.5

58.3

476

1829

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

4.2

58.2

233

537

ACC51

NOMESCO Finland

Release of median nerve

1.7

58.2

1392

8169

J01FA10

ATC

azithromycin; systemic

1.2

58.0

12133

103092

RJ414

NOMESCO Finland

10.0

57.9

119

114

L99

ICPC

Musculoskeletal disease other

2.6

57.8

433

1586

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.4

57.7

524

2130

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

57.7

1723

10714

NHG20

NOMESCO Finland

Fusion of talocrural joint

5.0

57.5

192

368

A03FA02

ATC

cisapride; oral, rectal

1.6

57.5

1571

9552

NB1AD

NOMESCO Finland

Shoulder CT examination

3.0

57.4

355

1154

Y96.9

ICD-10 Finland

Unspecified type of accident

2.8

57.3

391

1355

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

2.8

57.2

389

1343

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.2

57.2

623

2762

K08.3

ICD-10 Finland

Retained dental root

1.7

57.0

1297

7501

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.7

56.9

1308

7590

L04AB04

ATC

adalimumab; parenteral

2.7

56.8

409

1464

R96

ICPC

Asthma

1.6

56.7

1673

10369

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

56.6

3606

26142

RS221

NOMESCO Finland

2.9

56.5

352

1150

M54.3

ICD-10 Finland

Sciatica

1.8

56.5

1124

6244

WW200

NOMESCO Finland

Immunization

2.3

56.4

565

2410

S76

ICPC

Skin infection other

1.8

56.2

972

5161

L05

ICPC

Flank/axilla symptom/complaint

1.8

56.0

1033

5601

N18.0

ICD-10 Finland

End-stage renal disease

3.4

55.8

279

779

S20

ICPC

Corn/callosity

2.6

55.8

428

1589

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.6

55.7

1554

9496

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

55.6

1186

6728

R05FB02

ATC

cough suppressants and expectorants

1.3

55.6

7705

62323

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

55.6

1013

5471

M14.6

ICD-10 Finland

Neuropathic arthropathy

14.4

55.4

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.0

55.4

343

1115

R03DA04

ATC

theophylline; systemic, rectal

1.8

55.4

978

5229

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.3

55.3

556

2375

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

55.3

1833

11680

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

55.3

2228

14825

C01DA14

ATC

isosorbide mononitrate; oral

1.4

55.3

2755

19121

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

55.3

1109

6175

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

55.2

3224

23020

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.8

55.0

369

1265

E87.6

ICD-10 Finland

Hypokalaemia

2.1

55.0

627

2837

M92.4

ICD-10 Finland

Juvenile osteochondrosis of patella

184.9

54.9

M54.8

ICD-10 Finland

Other dorsalgia

2.0

54.9

774

3819

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.5

54.6

445

1709

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.5

54.4

464

1826

137

Kela drug reimbursment

Uraemia requiring dialysis

4.1

54.4

222

522

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

54.4

866

4468

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.1

54.3

221

518

ND1AD

NOMESCO Finland

Wrist CT examination

3.8

54.2

239

602

M89.88

ICD-10 Finland

Other specified disorders of bone, other

66.8

53.9

SPAT1167

SPAT

Insertion of urinary catheter

2.2

53.9

599

2679

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

4.5

53.5

196

415

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

8.0

53.4

125

150

H3603, E113

ICD-10 Finland

3.9

53.4

228

558

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.3

53.4

540

2315

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

53.3

1186

6810

ZZH20

NOMESCO Finland

Graft of patients own bone

6.0

53.3

152

242

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

3.4

53.3

270

762

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.7

53.3

1124

6358

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.8

53.2

369

1289

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

53.0

1118

6320

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4425

23489

1.93

310.81

4.3

4.2

240.1

244.3

u/l

1.27

4169

22135

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6155

33937

1.92

307.65

4.4

3.3

0.8

mmol/l

12.54

5696

31547

(3001604) Monocytes [#/volume] in Blood

15656

106637

1.89

307.65

8.4

5.7

0.6

e9/l

8.58

13859

91817

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15608

96610

2.20

307.65

9.3

5.6

1.2

mmol/l

4.47

14443

87054

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9309

60580

1.69

307.65

3.5

2.9

1766.9

1375.6

ng/l

10.02

8000

51523

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

14849

88718

2.25

307.65

3.3

2.2

79.9

1110.9

nmol/l

0.50

13510

79339

(3023368) Bacteria identified in Blood by Culture

9970

55950

2.07

307.65

5.9

4.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3407

15260

2.27

307.65

1.9

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5297

28409

1.95

307.65

3.4

2.5

21.0

22.5

10.97

4451

24208

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3983

18848

2.17

307.65

2.3

2.2

338.8

381.7

nmol/l

26.12

3666

17260

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6072

26510

2.50

307.65

7.8

5.5

1.0

mmol/l

0.39

5635

24581

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

15900

111423

1.82

307.65

7.8

5.9

10.6

11.3

umol/l

8.54

15132

105294

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14269

100125

1.72

307.65

5.0

3.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

5080

24597

2.17

307.65

2.4

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5616

30489

1.93

307.65

3.3

2.4

2.3

2.4

g/l

18.41

5182

28074

(40760888) Immunoglobulin light chains.free panel - Serum

1504

4474

3.31

307.65

4.1

3.2

—

(3019069) Monocytes/100 leukocytes in Blood

14673

100759

1.80

307.65

9.3

6.1

8.7

8.6

2.04

13850

94022

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

339

125

26.02

307.65

1.8

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

11467

72474

1.85

307.65

4.2

3.3

2.4

mmol/l

7.19

9922

62875

(3027945) Reticulocytes/100 erythrocytes in Blood

4460

23022

2.00

307.65

3.1

2.5

1.9

1.8

6.84

3927

20290

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1859

5821

3.17

307.65

4.0

3.1

5.5

3.5

ratio

0.26

159

439

(3037467) Urinalysis macro (dipstick) panel - Urine

19142

149330

1.68

307.65

6.2

4.3

—

(3022096) Basophils/100 leukocytes in Blood

14289

97231

1.80

307.65

8.9

5.9

0.7

4.53

13427

90343

(3006315) Basophils [#/volume] in Blood

15712

107163

1.89

307.65

8.4

5.7

0.0

e9/l

0.24

13916

92255

(3013826) Glucose [Moles/volume] in Serum or Plasma

17263

125582

1.79

307.65

6.8

4.5

6.7

mmol/l

0.86

16487

116996

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

11794

80713

1.67

307.65

4.9

3.5

73.4

61.3

ng/l

0.21

8667

54088

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4420

22909

1.99

307.65

2.1

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10029

64699

1.73

307.65

2.5

2.1

221.5

201.9

u/l

0.50

9411

60446

(3042936) Bacteria identified in Isolate by Culture

6096

28919

2.28

307.65

2.9

1.9

—

(3019198) Lymphocytes [#/volume] in Blood

15955

109824

1.88

307.65

8.5

5.7

1.8

1.9

e9/l

5.58

14278

96330

(3013707) Erythrocyte sedimentation rate by Westergren method

20853

159925

1.93

307.65

6.1

4.0

14.8

12.2

mm/h

95.20

19539

147505

(3020630) Protein [Mass/volume] in Serum or Plasma

4067

16354

2.59

307.65

3.2

2.5

66.1

66.5

g/l

2.86

3596

14809

(3018010) Neutrophils/100 leukocytes in Blood

14719

101997

1.78

307.65

8.6

5.8

58.5

57.1

33.37

13856

95071

(3044640) Blood type and Crossmatch panel - Blood

10316

67492

1.71

307.65

3.1

2.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

14922

103537

1.79

307.65

9.0

6.0

26.6

28.1

54.31

14004

96138

(3026008) Bacteria identified in Urine by Culture

10185

66733

1.70

307.65

4.1

3.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

6701

39933

1.78

307.65

1.9

1.7

1231.8

1163.2

nmol/l

6.06

5147

29883

(3022948) Iron [Moles/volume] in Serum or Plasma

6006

33063

1.92

307.65

3.3

2.4

11.8

13.1

umol/l

33.61

5546

30477

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16953

106631

2.29

307.65

10.8

6.2

1.2

mmol/l

2.35

14421

89648

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8852

52885

1.86

307.65

2.7

2.2

3.1

3.0

mg/l

4.91

7647

45014

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

862

364

23.14

307.65

2.2

2.0

63.9

61.2

ug/l

0.25

842

355

(3031040) Bacteria [#/volume] in Urine by Automated count

18621

143315

1.69

307.65

6.4

4.4

2151.9

1616.8

e6/l

0.45

279

1957

(3004588) Protein electrophoresis panel - Serum or Plasma

3601

13257

2.81

307.65

2.9

2.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

17410

123976

1.88

307.65

12.1

8.8

4.3

4.1

e9/l

16.89

15580

107781

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

11176

76179

1.65

307.65

4.5

3.2

—

0.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4226

15354

2.90

307.65

4.5

3.7

93.1

88.8

ng/l

1.51

3626

13153

(42870588) Differential panel, method unspecified - Blood

11593

72941

1.87

307.65

8.4

5.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4430

22845

2.00

307.65

2.1

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1906

6004

3.16

307.65

4.1

3.1

53.2

66.3

mg/l

0.59

1480

4912

(3032080) INR in Blood by Coagulation assay

12917

85448

1.81

307.65

10.8

8.6

1.2

inr

1.14

3540

24431

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10268

67651

1.69

307.65

3.3

2.5

56.7

58.6

u/l

1.58

9519

62155

(3024561) Albumin [Mass/volume] in Serum or Plasma

14350

92591

1.96

307.65

6.6

4.6

34.7

35.6

g/l

65.55

13388

85548

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6314

33442

2.02

307.65

2.2

1.8

—

(3018418) pH of Serum or Plasma

10697

63109

1.98

307.65

6.6

3.8

7.4

2.74

2247

11722

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

545

226

23.30

307.65

1.7

1.3

0.3

0.5

ug/l

4.51

384

131

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

21615

165947

2.04

307.65

11.2

7.2

80.2

78.4

u/l

5.23

20693

155624

(3013115) Eosinophils [#/volume] in Blood

16109

110680

1.90

307.65

8.7

5.9

0.2

e9/l

0.32

14366

96716

(3006504) Eosinophils/100 leukocytes in Blood

14621

100205

1.80

307.65

8.9

5.9

2.8

2.9

3.83

13750

93048

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1900

5994

3.15

307.65

4.1

3.1

40.2

44.8

mg/l

0.50

1478

4906

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7497

46833

1.71

305.94

1.4

1.3

1.4

1.7

u/ml

2.12

2031

12286

(3005719) IgG [Mass/volume] in Serum or Plasma

3226

15431

2.11

302.67

3.7

2.6

10.1

10.6

g/l

7.57

2937

14110

(3007164) IgA [Mass/volume] in Serum or Plasma

6648

40716

1.72

288.86

1.8

1.4

2.5

2.4

g/l

0.73

4079

24253

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7984

51349

1.66

288.63

3.0

2.3

—

(3023520) Reticulocytes [#/volume] in Blood

3424

17037

2.03

287.93

3.1

2.5

70.9

69.8

e9/l

0.98

2657

12819

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

7407

46768

1.68

287.09

2.0

1.7

1.2

mg/l

0.10

5816

35544

(3021960) Folate [Moles/volume] in Serum or Plasma

7680

49223

1.66

279.68

1.7

1.5

20.8

20.6

nmol/l

0.37

6587

41951

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4299

23405

1.88

276.57

7.7

7.0

5.1

kpa

1.50

4084

22330

(3037756) Immunofixation for Serum or Plasma

1245

3975

3.06

275.14

2.0

1.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4291

23394

1.87

274.68

7.7

7.0

11.8

12.5

kpa

14.60

4073

22312

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1898

7592

2.47

271.37

3.0

2.1

3.8

g/l

0.73

1290

5394

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1902

7619

2.47

271.09

3.0

2.1

7.5

7.4

g/l

1.87

1344

5652

(3003396) Base excess in Arterial blood by calculation

4281

23416

1.87

270.90

7.8

6.9

1.3

1.0

mmol/l

4.36

3449

18457

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1899

7607

2.47

270.65

3.0

2.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

12651

91939

1.56

268.84

3.7

2.8

134.5

126.1

ug/l

2.81

11690

84826

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

12230

88212

1.56

268.76

2.3

2.0

95.3

96.6

pmol/l

2.22

6588

44871

(3016502) Oxygen saturation in Arterial blood

3893

20811

1.90

263.97

8.0

7.3

95.5

95.7

1.53

3731

20041

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1778

7102

2.47

254.55

3.0

2.1

9.8

10.3

g/l

4.22

1415

5917

(3028026) IgM [Mass/volume] in Serum or Plasma

2565

11985

2.13

253.47

2.3

1.8

1.3

g/l

0.82

2296

10910

(3026782) Osmolality of Urine

6607

41603

1.66

253.32

3.6

2.7

521.4

543.2

mosm/kgh2o

13.10

5790

35193

(3000850) Epithelial cells [#/volume] in Urine

6981

44637

1.64

251.77

3.3

2.5

5.5

5.9

e6/l

2.01

6274

38779

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1780

7153

2.45

251.44

3.1

2.1

3.1

g/l

0.88

1311

5527

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1118

3609

3.02

241.99

3.5

3.0

—

(3037522) Nuclear Ab [Titer] in Serum

4872

28627

1.74

239.75

1.5

1.3

583.2

541.8

titre

0.75

1105

5902

(3002582) Erythrocytes [#/volume] in Urine

9338

64621

1.56

238.54

4.3

3.1

64.5

92.4

e6/l

1.10

7547

48964

(3020779) Urea [Moles/volume] in Serum or Plasma

3421

18081

1.90

238.37

11.5

6.9

10.7

9.7

mmol/l

12.02

3254

17187

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1138

3747

2.96

237.79

1.8

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3591

19370

1.87

234.66

6.1

3.7

5.9

5.8

kpa

2.53

3460

18815

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2065

9145

2.23

232.70

1.9

1.7

1.6

1.5

g/l

1.53

1792

7743

(3002032) Base excess in Venous blood by calculation

3573

19329

1.86

231.10

6.2

3.7

1.9

mmol/l

0.33

2963

15837

(3012544) pH of Venous blood

3670

20068

1.84

229.26

6.1

3.7

7.4

0.04

105

(3030467) Casts [#/volume] in Urine by Automated count

8667

59400

1.56

228.94

4.2

3.1

0.4

e6/l

0.14

6905

44226

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3624

19771

1.85

227.96

2.6

2.2

0.2

g/l

7.92

3331

18382

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1605

6438

2.45

227.06

3.2

2.3

1.0

0.9

g/l

0.54

1327

5500

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2501

12055

2.06

226.47

1.7

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3544

19244

1.85

226.16

8.5

7.7

118.0

121.3

g/l

17.62

3423

18560

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6190

39458

1.63

221.37

3.4

3.0

2.5

mmol/l

7.58

5423

34318

(3018095) Leukocytes [#/volume] in Urine

10571

76077

1.51

220.51

5.0

3.6

98.9

101.7

e6/l

0.11

8032

52945

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1824

7840

2.29

220.44

2.1

1.9

2.2

2.3

ug/l

0.09

1588

6883

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

24991

216925

1.87

219.44

25.8

13.5

23.0

23.5

mg/l

2.04

21649

170797

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1486

5861

2.48

217.84

1.4

1.3

—

(3000991) Gas panel - Venous blood

3262

17543

1.86

213.78

10.3

7.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

8087

55359

1.54

210.94

3.2

2.5

3394.6

4712.4

umol/l

2.47

6982

47807

(36304419) Bacteria [Presence] in Urine

8363

57922

1.53

205.51

4.1

3.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

4390

26078

1.71

204.24

8.6

6.8

103.8

104.4

mmol/l

13.20

4285

25524

(3019060) Gas panel - Arterial blood

2624

13329

1.96

204.00

4.9

4.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3311

18211

1.82

201.04

8.2

6.6

1.3

1.4

mmol/l

0.38

3194

17528

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1460

5932

2.41

200.26

2.9

2.1

37.2

37.7

g/l

2.62

1203

5042

(3035350) Ketones [Presence] in Urine by Test strip

13798

106173

1.46

198.05

5.1

3.6

0.0

estimate

1.54

2722

19374

(3009261) Glucose [Presence] in Urine by Test strip

13940

107680

1.45

194.71

5.2

3.7

0.0

estimate

0.16

2740

19362

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5152

32340

1.63

192.41

2.6

2.1

29.8

0.15

4995

31357

(3015736) pH of Urine

11153

82840

1.46

189.81

4.6

3.4

6.2

5.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

13769

106619

1.44

186.52

6.7

4.9

0.0

estimate

0.12

2788

19760

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2524

13040

1.92

185.76

4.9

3.5

5.2

5.1

kpa

1.29

2325

12016

(3009343) pH of Capillary blood

2499

12870

1.92

185.68

4.9

3.5

7.4

0.45

359

1641

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

810

2540

3.08

183.92

8.0

6.0

11.9

11.7

mg/l

0.55

747

2306

(3024354) Oxygen [Partial pressure] in Venous blood

2938

15990

1.83

183.59

5.0

3.2

4.7

4.6

kpa

3.04

2813

15482

(3044927) Protein electrophoresis panel - Urine

661

1832

3.48

183.42

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2415

12440

1.92

179.03

4.9

3.4

1.8

mmol/l

0.44

1824

9203

(3019225) pH of Specimen

3628

21160

1.72

178.36

7.0

3.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1083

4043

2.60

177.52

7.8

5.3

1049.5

1427.9

iu/ml

0.30

218

560

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1368

5699

2.34

176.92

3.0

2.1

0.0

g/l

0.69

1233

5178

(3033658) Prothrombin time (PT) actual/Normal

7800

54620

1.49

175.83

5.8

3.8

90.8

90.5

0.38

7598

53228

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1597

7155

2.18

173.42

2.5

2.3

395.0

560.7

ug/l

1.75

1489

6695

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

910

3219

2.74

165.85

1.3

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2413

12728

1.87

165.75

7.5

6.9

24.9

24.6

mmol/l

2.94

2256

11874

(3017181) Myelocytes/100 leukocytes in Blood

3109

17772

1.74

163.25

4.8

4.0

0.9

0.03

1036

4864

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1833

8893

2.02

160.99

1.6

1.5

15.0

14.6

u/ml

0.04

243

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1262

5288

2.32

160.78

3.1

2.2

0.0

g/l

0.17

1131

4784

(3002179) Metamyelocytes/100 leukocytes in Blood

2873

16144

1.77

159.99

4.5

3.8

0.6

0.10

774

3512

(40758558) Short blood count panel - Blood

7712

54698

1.47

159.77

9.3

6.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9452

69792

1.43

157.25

4.1

3.2

33.1

33.9

u/l

0.56

8958

65979

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6097

41395

1.51

156.53

4.7

3.7

321.6

460.7

ng/l

2.12

4780

31872

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2308

12248

1.86

155.10

1.9

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3091

17915

1.72

153.85

2.7

2.3

7.3

7.0

ug/l

0.25

2525

15544

(3000475) Leukocytes [#/volume] in Synovial fluid

1189

4956

2.33

153.23

1.8

1.6

13542.7

13893.5

e6/l

0.09

877

3579

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5499

36715

1.52

152.25

1.3

37.0

36.7

iu/ml

0.04

1730

11389

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1972

10019

1.93

151.36

7.1

4.0

24.1

24.2

mmol/l

0.54

1756

9056

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1346

5945

2.20

151.02

2.1

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1252

5371

2.27

150.77

1.5

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1227

5231

2.28

149.96

3.1

2.2

0.0

g/l

0.00

1124

4772

(40760892) CBC W Ordered Manual Differential panel - Blood

6721

46890

1.47

149.67

6.0

4.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5472

36684

1.52

148.05

3.4

2.7

1.3

1.2

e6/l

0.08

3288

20699

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5216

34622

1.53

147.86

1.3

17.1

12.3

u/ml

2.93

1890

13223

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1465

6745

2.12

147.85

2.8

2.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

25084

222155

1.69

147.38

27.7

15.6

139.2

139.7

mmol/l

143.27

24653

216277

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

670

2147

3.01

146.36

1.3

51.4

30.6

nmol/l

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1371

6190

2.16

145.47

2.0

1.6

0.2

g/l

0.31

1310

5855

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

19883

167946

1.42

145.35

4.6

4.1

15.0

14.8

pmol/l

17.64

18157

152429

(3021440) Promyelocytes/100 leukocytes in Blood

2920

16943

1.71

144.15

4.9

4.0

0.1

2.45

970

4503

(3000494) Fungus identified in Specimen by Culture

3923

24551

1.60

143.88

1.7

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

25107

222721

1.68

142.46

27.9

15.7

4.0

mmol/l

14.61

24623

216423

(3037121) Protein [Mass/volume] in Urine

1508

7132

2.06

141.58

3.3

3.2

0.4

0.3

g/l

1.30

674

2990

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1119

4701

2.31

141.45

1.8

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1391

6389

2.12

141.13

2.0

1.6

1.2

g/l

0.18

1333

6067

(3022217) INR in Platelet poor plasma by Coagulation assay

4322

27832

1.56

139.72

27.6

24.3

1.3

inr

0.08

557

3965

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2962

17408

1.69

139.12

6.4

3.5

1.2

mmol/l

0.35

2749

15021

(3025159) Blasts/100 leukocytes in Blood

2759

15991

1.71

136.32

4.9

4.1

0.3

0.2

0.09

849

3822

(3014007) Fractional oxyhemoglobin in Arterial blood

2329

12933

1.77

133.89

9.9

8.8

93.6

93.9

1.79

2323

12883

(3003181) Sodium [Moles/volume] in Urine

918

3629

2.45

133.01

1.5

1.4

61.4

62.2

mmol/l

0.24

714

2887

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2314

12893

1.77

131.39

9.9

8.7

0.7

1.12

2297

12820

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2313

12914

1.76

130.35

9.8

8.6

1.4

0.40

2293

12831

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1067

4547

2.27

130.29

1.9

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2049

11045

1.82

130.00

10.3

9.3

—

(3017704) Immunofixation for Urine

394

978

3.86

128.56

1.8

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

17108

142143

1.36

128.37

4.0

3.0

56.9

47.4

u/l

21.42

15959

132238

(3021788) Differential panel - Synovial fluid

920

3740

2.38

125.24

1.7

1.5

—

(3021589) Normoblasts [#/volume] in Blood

12088

95447

1.35

125.07

14.7

9.2

0.0

e9/l

0.48

10087

78041

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3812

24411

1.56

125.01

3.7

2.7

8.1

8.4

umol/l

0.36

3248

21103

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3429

21443

1.59

124.68

4.7

3.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1430

6966

2.00

123.35

1.7

1.6

183.2

263.0

titre

0.87

299

(3010838) Calcium [Moles/time] in 24 hour Urine

381

953

3.83

122.98

1.7

1.6

6.4

5.4

mmol/24h

0.49

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

22811

199421

1.46

122.84

5.6

4.8

2.2

2.1

mu/l

0.34

21070

182530

(3017143) Hepatitis C virus Ab [Presence] in Serum

3703

23680

1.56

121.93

1.8

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6363

45362

1.43

121.91

1.7

30645918.2

33512964.8

pmol/l

0.15

5283

37204

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4998

34081

1.48

121.17

3.7

2.8

3.1

e6/l

0.18

2834

18235

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1412

6890

1.99

121.17

3.6

3.1

0.3

0.4

u/ml

2.86

823

3915

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

803

3116

2.49

121.02

3.7

2.8

1141.2

6322.2

u/ml

0.90

179

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1058

4633

2.21

120.86

1.7

1.6

—

(3022313) Gas panel - Capillary blood

1766

9349

1.84

118.46

5.2

3.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1973

10805

1.79

118.35

9.9

8.9

24.5

24.3

mmol/l

1.38

1814

10084

(3011397) Hemoglobin [Presence] in Urine by Test strip

6950

50652

1.40

116.44

4.9

3.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2255

12890

1.72

116.31

8.9

6.8

24.9

mmol/l

0.52

2240

12757

(40761535) Cells panel - Urine sediment

2866

17478

1.62

115.10

4.7

3.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2191

12492

1.72

113.97

5.0

3.3

124.4

129.0

g/l

18.34

2139

12203

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1789

9634

1.81

113.36

4.4

2.8

1.3

1.2

1.48

1780

9582

(3029937) Albumin [Presence] in Urine by Test strip

7695

57261

1.38

113.08

5.9

4.0

0.0

estimate

0.85

2684

19115

(3026250) Tacrolimus [Mass/volume] in Blood

337

822

3.92

112.71

40.0

34.3

7.4

7.2

ug/l

0.47

313

737

(3010375) cycloSPORINE [Mass/volume] in Blood

338

841

3.85

109.95

28.9

27.9

115.9

114.8

ug/l

0.10

270

716

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1167

5515

2.05

109.30

5.0

3.7

1.7

1.5

mg/l

11.08

1076

5054

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1746

9454

1.80

108.51

4.4

2.7

0.7

0.11

1680

9071

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1293

6355

1.97

108.48

2.1

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

615

2216

2.67

107.91

1.3

1.2

70.0

61.2

u/l

1.28

425

1472

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

822

3396

2.33

107.75

1.9

1.7

—

(36660697) Celiac disease serology panel - Serum

2763

16967

1.60

107.39

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1005

4521

2.15

107.18

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1005

4521

2.15

107.18

1.5

1.3

—

(40768797) Stomach Pathology biopsy report

4354

29564

1.47

106.25

1.3

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

561

1945

2.77

106.07

2.5

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1571

8307

1.84

105.45

1.3

1.2

1.3

0.9

u/ml

0.57

151

743

(3019150) Specific gravity of Urine by Refractometry

6405

46758

1.39

104.13

5.6

4.0

1.0

kg/l

0.48

964

7141

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10417

81994

1.33

103.30

5.6

3.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1547

8195

1.84

103.18

5.6

3.8

24.9

mmol/l

0.02

1419

7562

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1182

5734

2.00

102.85

1.6

1.4

16.4

14.8

iu/ml

0.15

131

(3013512) EKG study

8118

61739

1.35

101.29

4.7

3.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1256

6262

1.94

100.96

1.4

273.0

272.9

ug/g

0.00

761

3582

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

809

3443

2.26

98.88

1.6

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

654

2534

2.48

98.82

1.7

1.5

57.2

58.2

0.27

438

1574

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2838

17868

1.56

98.61

3.4

2.9

220.6

202.6

ng/l

0.93

2599

16255

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1258

6329

1.93

98.40

1.7

1.6

0.7

8.1

iu/ml

1.44

291

1376

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3107

19979

1.53

98.13

3.2

2.4

34.5

46.5

u/l

1.98

2644

17059

(3044941) Cell count panel - Synovial fluid

762

3178

2.31

97.68

1.6

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1606

8748

1.79

97.55

2.3

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

1277

6502

1.90

96.30

3.7

3.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

921

4181

2.13

95.86

3.2

2.7

33.0

34.0

umol/l

0.65

775

3527

(40761511) CBC panel - Blood by Automated count

25037

225343

1.51

92.71

22.5

12.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1757

9968

1.72

92.38

4.8

3.3

25.3

mmol/l

0.12

1699

9675

(3048689) Calprotectin [Mass/mass] in Stool

3875

26442

1.45

90.72

2.5

2.3

148.0

133.4

ug/g

1.46

3089

20591

(1616796) Gas panel - Central venous blood

970

4604

2.03

89.58

4.7

3.4

—

(3020891) Body temperature

1495

8182

1.77

89.17

5.8

4.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1468

8012

1.78

88.37

2.1

1.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

25394

229618

1.53

87.66

27.4

15.8

79.4

76.3

umol/l

22.80

25388

229523

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

862

3951

2.10

87.44

1.3

1.2

98.1

162.4

titre

0.76

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

450

1540

2.80

87.23

1.3

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

1337

7146

1.81

86.30

4.6

4.0

1.3

1.4

mmol/l

1.72

1310

7027

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

957

4597

2.01

85.45

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

460

1619

2.72

84.53

2.0

0.6

1.3

g/24h

1.66

(3011412) CD3 cells [#/volume] in Blood

512

1906

2.58

84.14

2.5

2.4

1.2

e9/l

0.23

328

1125

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

644

2665

2.32

84.04

1.8

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2417

15195

1.56

83.80

1.5

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5001

36136

1.38

83.77

2.0

1.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1518

8497

1.73

83.57

5.5

4.8

1.8

1.6

3.56

1430

7963

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

624

2559

2.34

83.14

1.6

1.4

—

(3023419) Bacteria identified in Sputum by Culture

605

2454

2.37

82.65

2.8

2.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1548

8757

1.72

82.00

2.3

1.9

39.9

39.4

u/l

0.40

1356

7732

(3007930) Methemoglobin/Hemoglobin.total in Blood

1488

8340

1.73

81.49

5.6

4.9

0.9

0.74

1401

7817

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1030

5163

1.93

81.26

3.7

3.0

25.0

24.8

mmol/l

0.67

930

4504

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

686

2960

2.23

81.06

1.6

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1609

9229

1.69

80.96

5.1

3.9

49.9

48.1

2.25

1591

9131

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

554

2187

2.43

80.39

1.9

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

745

3344

2.14

79.76

3.4

3.3

1.4

0.16

596

2591

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

407

1387

2.81

79.54

1.8

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

386

1281

2.88

79.23

1.7

1.5

7.0

6.3

u/l

0.25

213

597

(3009508) Creatinine [Moles/volume] in Urine

8489

66731

1.30

78.89

3.7

3.2

6.8

7.5

mmol/l

32.71

7221

55838

(40767503) Oxygen content in Capillary blood by calculation

906

4416

1.98

77.56

3.1

2.4

15.6

16.4

5.98

493

2240

(3047181) Lactate [Moles/volume] in Blood

1203

6440

1.81

77.11

6.2

5.6

1.3

mmol/l

0.85

1069

5680

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

859

4118

2.01

77.08

1.7

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

497

1905

2.50

76.86

1.5

1.4

142151.3

125695.1

e6/l

0.19

333

1317

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

377

1265

2.85

75.85

1.3

1.2

94.7

86.8

u/l

0.63

336

1093

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

849

4090

2.00

75.14

1.7

1.4

22.1

22.0

u/ml

0.00

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4239

30311

1.38

74.69

1.8

1.6

—

(3025941) Bacteria identified in Stool by Culture

1974

12171

1.58

74.15

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

305

925

3.15

73.32

1.2

1.1

3.4

3.8

iu/ml

0.39

(3008757) Leukocyte morphology finding [Identifier] in Blood

545

2228

2.35

73.15

3.9

3.6

—

(3042733) HLA Ab [Presence] in Serum

238

627

3.62

71.43

4.6

4.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

362

1233

2.81

70.86

1.3

1.2

26.7

22.9

u/l

0.72

318

1044

(3010421) pH of Blood

1047

5525

1.83

70.28

5.8

3.6

7.4

0.07

915

4677

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

625

2752

2.18

70.25

1.6

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

696

3207

2.08

69.58

1.7

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

869

4354

1.92

68.57

1.7

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

389

1400

2.66

68.49

2.3

2.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3784

26912

1.39

68.29

10.0

6.8

—

(44790049)

524

2173

2.31

68.07

1.8

1.5

—

(44790047)

524

2173

2.31

68.07

1.8

1.5

—

(44806118)

524

2173

2.31

68.07

1.8

1.5

—

(44790048)

524

2173

2.31

68.07

1.8

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

944

4873

1.87

67.97

3.9

3.3

8.3

kpa

0.65

899

4508

(1175426) CD3 cells/100 lymphocytes in Blood

407

1506

2.59

67.77

2.2

2.1

74.2

72.3

1.75

384

1449

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

401

1474

2.60

67.68

2.2

2.1

13.7

14.0

0.11

183

706

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

25326

230441

1.45

67.54

15.4

10.1

25.5

26.2

u/l

4.70

24581

222030

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1010

5347

1.82

67.06

1.3

8.0

7.9

u/ml

0.03

177

868

(3017732) Neutrophils [#/volume] in Blood

2272

14763

1.50

66.85

3.5

2.8

4.2

4.1

e9/l

0.40

1621

11346

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1471

8667

1.64

66.47

1.1

1.4

10.1

u/ml

1.30

120

(3027315) Oxygen [Partial pressure] in Blood

933

4834

1.86

66.39

5.8

3.7

8.5

8.7

kpa

2.66

919

4705

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

996

5267

1.82

66.37

1.3

6.3

5.6

u/ml

0.11

119

560

(3012501) Base excess in Blood by calculation

928

4801

1.86

66.35

5.8

3.7

2.7

2.6

mmol/l

1.11

672

3236

(3013290) Carbon dioxide [Partial pressure] in Blood

928

4803

1.86

66.26

5.8

3.7

5.0

kpa

0.38

914

4675

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

772

3759

1.97

66.25

1.7

1.4

115.6

115.7

u/ml

0.01

167

823

(3008295) Osmolality of Serum or Plasma

489

1994

2.35

66.04

1.5

1.4

276.3

279.3

mosm/kgh2o

1.95

376

1537

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

858

4339

1.90

65.82

1.3

1.2

4.5

13.3

u/ml

0.84

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1125

6184

1.76

65.77

3.6

2.5

3.7

3.6

g/l

1.82

1071

5873

(3039000) Anion gap in Blood

883

4510

1.88

65.71

6.7

6.6

11.1

11.2

mmol/l

0.31

802

4053

(3018572) Chloride [Moles/volume] in Blood

883

4511

1.88

65.66

6.7

6.6

104.2

105.1

mmol/l

5.87

802

4054

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1073

5821

1.78

65.65

1.3

26.8

39.6

u/ml

1.09

355

(21494815) CD4 cells/100 lymphocytes in Specimen

435

1689

2.46

65.49

2.3

2.2

41.2

41.5

0.04

218

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1038

5588

1.79

65.18

2.3

2.0

11.5

11.1

mg/l

0.92

948

5182

(3014271) Vancomycin [Susceptibility]

309

1024

2.88

63.68

3.4

2.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

1119

6205

1.74

63.42

4.9

4.3

3.9

mmol/l

0.37

1048

5841

(3021901) Oxygen saturation in Capillary blood

760

3739

1.95

63.29

3.2

2.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

813

4099

1.91

62.94

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

701

3370

2.00

62.39

1.6

0.7

0.8

g/l

0.97

522

2549

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1154

6484

1.72

62.37

3.1

2.3

92.5

91.9

0.32

1071

6010

(4062490)

498

2101

2.27

62.16

1.5

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

498

2103

2.27

62.02

1.5

1.4

2.7

2.9

g/l

2.33

347

1470

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

673

3197

2.02

61.93

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2534

17069

1.45

61.85

3.1

2.6

61.2

65.9

ml/min/173m2

6.83

1101

6730

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

403

1551

2.49

61.85

2.5

1.8

4.0

3.8

mg/l

0.29

385

1468

(3024139) IgG subclass 3 [Mass/volume] in Serum

497

2103

2.26

61.60

1.5

1.4

0.4

g/l

2.46

348

1467

(3005322) IgE [Units/volume] in Serum or Plasma

2035

13155

1.50

61.18

1.4

1.3

274.6

233.6

u/ml

0.36

1892

12129

(3027135) IgG subclass 1 [Mass/volume] in Serum

496

2105

2.26

61.04

1.5

1.4

6.4

6.8

g/l

1.10

348

1465

(3036603) Volume of Urine

358

1310

2.61

61.02

1.7

1.6

1896.8

1992.8

0.47

292

(3028271) Lactate [Moles/volume] in Capillary blood

688

3322

1.99

60.48

2.4

1.8

1.6

1.7

mmol/l

3.50

677

3246

(3006184) Hemoglobin [Mass/volume] in Capillary blood

903

4769

1.82

60.40

2.5

2.2

123.4

130.0

g/l

10.96

679

3437

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

844

4373

1.86

60.03

1.3

1.2

6.7

5.5

u/ml

0.15

338

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

766

3858

1.91

59.48

1.3

279.4

270.8

u/ml

0.31

503

2426

(3048929) Epstein Barr virus Ab [Presence] in Serum

1128

6382

1.70

59.41

1.3

—

(3024928) Oxygen saturation in Venous blood

829

4295

1.86

58.98

5.3

3.1

—

(3016038) Potassium [Moles/volume] in Urine

359

1339

2.56

58.87

1.3

1.2

32.4

34.8

mmol/l

1.19

293

1146

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

15803

136307

1.23

58.64

3.1

2.9

—

(3036489) Thrombin time

1330

7896

1.63

58.16

2.8

2.0

21.6

21.5

0.19

1152

6889

(3035637) Corticotropin [Mass/volume] in Plasma

561

2552

2.11

58.04

1.6

1.5

—

(3024471) HLA-A [Type]

218

633

3.28

56.40

1.0

—

(3042631) Mycobacterium sp identified in Specimen

587

2746

2.05

56.36

2.8

2.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

354

1343

2.52

56.05

1.5

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

22561

202767

1.29

56.01

21.5

12.8

80.3

81.0

ml/min/173m2

4.94

19392

166595

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

252

801

3.00

56.01

3.2

2.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

486

2128

2.19

55.45

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1052

5973

1.70

54.65

3.6

2.4

200.3

189.0

3.38

983

5641

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2051

13575

1.47

54.59

3.2

3.3

4.4

4.5

pmol/l

3.34

1759

12034

(3047189) Immunofixation for 24 hour Urine

255

834

2.92

53.90

2.2

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

574

2708

2.03

53.86

1.5

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3457

25085

1.35

53.85

1.9

1.7

1.6

1.4

10.98

2959

22043

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2102

14020

1.46

53.72

2.4

2.2

12.1

12.4

nmol/l

1.22

1820

12511

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

584

2776

2.02

53.67

1.5

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

222

672

3.15

53.67

2.0

1.7

63722.8

24819.2

u/ml

0.45

(3024932) HLA-DR beta [Type]

212

625

3.23

53.54

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

345

1323

2.49

53.42

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

572

2705

2.03

53.33

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

567

2678

2.03

53.05

1.5

1.4

—

(4010399)

2284

15510

1.43

52.97

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

567

2685

2.02

52.67

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

566

2682

2.02

52.48

1.5

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

446

1930

2.21

52.41

1.6

1.5

28.3

30.7

0.80

287

1180

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

439

1892

2.22

52.11

3.3

2.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

354

1397

2.42

51.54

2.7

2.5

510.2

538.8

e6/l

0.33

297

1155

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1011

5770

1.69

51.50

1.1

8.6

6.5

u/ml

0.36

725

(3009214) Lutropin [Units/volume] in Serum or Plasma

986

5599

1.69

51.18

1.5

1.4

10.3

10.4

u/l

0.02

788

4539

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

343

1342

2.44

50.89

2.8

2.5

0.2

e9/l

0.20

297

1152

(3012565) Volume of 24 hour Urine

275

970

2.70

50.50

2.6

2.1

1857.6

1979.2

1.12

261

843

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

446

1960

2.18

50.46

1.7

—

(3010503) CD19 cells [#/volume] in Blood

312

1181

2.52

49.69

2.5

2.6

0.2

0.3

e9/l

0.69

304

1140

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

373

1540

2.31

49.07

1.8

1.5

—

(3018133) Calcium [Moles/volume] in Urine

136

315

4.11

49.05

2.6

2.0

2.7

2.5

mmol/l

0.46

126

282

(3041096) Erythrocytes [Presence] in Urine by Automated

7128

57349

1.24

48.96

4.7

3.3

—

(3034770) Mitochondria Ab [Titer] in Serum

1001

5797

1.66

48.21

1.3

1.2

825.3

1038.1

titre

0.49

177

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1671

10940

1.48

46.81

3.5

2.6

0.3

e6/l

0.31

1631

10633

(3044889) 12 lead EKG panel

17116

150347

1.20

46.78

4.5

3.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

133

316

4.01

46.38

5.5

5.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

252

895

2.69

45.71

1.7

1.6

4.7

5.9

nmol/l

0.18

215

742

(3020961) Endomysium IgA Ab [Titer] in Serum

1543

10020

1.49

44.99

1.1

286.8

217.8

titre

0.43

258

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

527

2579

1.96

44.63

2.3

2.1

32.5

0.07

521

2558

(3007566) Smooth muscle Ab [Titer] in Serum

994

5868

1.63

44.36

1.3

1.2

119.0

130.9

titre

0.18

527

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

21867

197173

1.24

44.04

6.6

5.7

40.4

39.7

mmol/mol

17.81

20153

182019

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

281

1073

2.50

44.00

1.2

1.1

32.3

24.7

u/l

0.78

219

823

(3000093) Morphology [Interpretation] in Blood Narrative

427

1954

2.09

43.59

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

280

1074

2.49

43.43

1.2

1.1

96.7

84.9

u/l

0.75

230

851

(40768804) Tissue Pathology biopsy report

10443

88100

1.20

42.97

2.2

2.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1712

11450

1.45

42.83

2.5

2.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

447

2099

2.04

42.57

3.4

3.2

61.2

57.8

2.35

309

1343

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

423

1953

2.07

42.18

3.8

3.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

770

4326

1.71

41.58

1.3

1.2

44.7

43.5

u/ml

0.07

417

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

468

2269

1.97

40.76

1.2

1.1

0.9

2.2

iu/ml

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

927

5498

1.62

40.59

1.3

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

339

1460

2.22

40.42

2.7

2.6

699.6

745.7

e6/l

0.20

137

585

(3023420) DNA double strand Ab [Units/volume] in Serum

459

2221

1.98

40.21

1.8

1.5

40.0

29.2

iu/ml

0.45

101

(3014765) Yersinia sp identified in Stool by Organism specific culture

1033

6316

1.57

39.80

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1034

6330

1.57

39.62

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1024

6257

1.57

39.56

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1036

6349

1.57

39.51

1.5

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

270

1067

2.41

39.32

1.8

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

271

1074

2.41

39.22

1.8

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

112

266

4.00

39.15

13.2

10.0

5.4

5.1

mmol/l

0.33

112

266

(40768446) Kidney Pathology biopsy report

216

770

2.67

38.98

2.1

1.6

—

(3007461) Platelets [#/volume] in Blood

26083

241095

1.39

38.81

35.4

20.1

257.1

252.3

e9/l

24.16

25593

234451

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

381

1746

2.08

38.80

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

381

1746

2.08

38.80

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

381

1746

2.08

38.80

1.6

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

259

1011

2.44

38.75

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

259

1011

2.44

38.75

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

312

1326

2.24

38.44

1.2

1.1

—

(3010813) Leukocytes [#/volume] in Blood

26101

241326

1.39

38.40

35.4

20.1

7.0

6.7

e9/l

42.12

25556

233932

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

293

1214

2.30

38.34

1.8

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

237

892

2.53

38.33

1.9

2.1

106.2

137.5

umol/l

1.10

127

469

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

242

920

2.51

38.32

1.2

1.1

—

(3035941) MCH [Entitic mass]

26090

241238

1.38

38.08

35.2

20.0

30.3

2.68

25808

237584

(3004616) Nuclear Ab [Presence] in Serum

502

2553

1.88

37.94

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

150

443

3.22

37.93

2.1

1.7

—

(3024731) MCV [Entitic volume]

26090

241266

1.38

37.78

35.3

20.0

91.4

90.9

60.47

25806

237607

(3022145) Colonoscopy Study observation

3213

24166

1.29

37.77

1.4

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

26091

241287

1.38

37.67

35.4

20.0

4.4

4.5

e12/l

317.14

25550

233887

(3003327) Ova and parasites identified in Stool by Light microscopy

1141

7225

1.52

37.50

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

568

3024

1.80

37.06

1.3

1.2

4.4

3.8

u/ml

0.64

241

1369

(3000963) Hemoglobin [Mass/volume] in Blood

26091

241359

1.37

36.90

35.6

20.2

131.0

135.2

g/l

307.65

25806

237738

(3012516) Albumin [Mass/volume] in Urine

7534

62418

1.20

36.15

3.8

3.2

877.9

390.0

mg/l

8.51

4942

38514

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

269

1103

2.33

36.10

2.4

2.8

41.4

38.8

0.92

372

(3036670) Protein [Mass/volume] in Synovial fluid

180

609

2.81

35.94

1.3

1.2

40.3

39.5

g/l

0.30

324

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

861

5172

1.60

35.78

1.5

1.3

600.5

529.7

mg/l

0.79

818

4918

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3458

26425

1.27

35.71

4.6

4.5

33.2

32.5

2.85

2371

17903

(1761868) Lipid panel - Serum or Plasma

6975

75569

0.83

35.52

3.0

2.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

433

2145

1.93

35.47

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2048

14578

1.36

35.35

2.4

28.1

25.5

au/ml

0.27

813

(3008898) HLA-B27 [Presence]

1076

6817

1.52

35.27

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

190

670

2.70

35.08

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

773

4547

1.63

35.02

1.4

1.3

3.8

3.7

mmol/l

0.88

730

4273

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

431

2143

1.92

34.93

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

414

2040

1.94

34.47

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

203

748

2.58

34.36

1.9

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

724

4212

1.65

34.28

3.5

3.1

0.8

nmol/l

1.10

565

3253

(3022229) Phosphate [Moles/volume] in Urine

107

5.68

33.97

3.3

2.0

18.7

19.0

mmol/l

0.04

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

508

2697

1.80

33.49

2.6

2.0

26.0

26.3

mg/l

0.03

122

710

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

203

759

2.55

33.36

2.5

2.0

29.3

0.00

186

726

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

569

3129

1.74

33.25

1.3

1.2

3.1

4.0

u/ml

0.71

196

1078

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

207

783

2.52

33.21

1.4

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

107

278

3.66

33.04

3.4

2.9

—

(3006245) CD3-CD19+ cells/100 cells in Blood

205

776

2.52

32.84

2.6

2.2

8.7

11.2

2.62

183

730

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1871

13311

1.36

32.33

1.3

54.7

48.9

au/ml

0.32

563

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

173

608

2.71

32.20

1.9

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

7832

65690

1.18

31.70

4.4

3.9

16.0

8.3

mg/mmol

18.00

5065

40583

(3039162) Centromere protein B Ab [Units/volume] in Serum

494

2647

1.78

31.60

1.3

1.2

62.5

53.5

u/ml

0.39

173

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

250

1057

2.25

31.30

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

250

1057

2.25

31.30

1.8

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

250

1057

2.25

31.30

1.8

1.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2956

22501

1.27

31.22

3.6

4.0

18.7

23.7

ug/l

0.62

2436

18116

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

250

1059

2.25

31.16

1.7

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

356

1733

1.96

30.77

1.3

1.2

177.8

183.7

titre

0.05

299

(3038026) Centromere Ab [Units/volume] in Serum

344

1655

1.98

30.76

1.3

1.2

57.2

52.6

u/ml

0.07

(3045142) Bone marrow Pathology biopsy report

428

2214

1.85

30.75

1.4

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

355

1730

1.96

30.59

1.3

1.2

82.7

181.5

titre

1.42

(3029634) Reagin Ab [Titer] in Serum by VDRL

512

2808

1.74

30.24

2.2

2.0

13.1

5.8

titre

0.58

(3025577) Chromium [Mass/volume] in Blood

270

1197

2.15

30.09

2.2

2.0

2.7

2.4

ug/l

0.44

232

989

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

565

3197

1.69

29.80

1.3

36.1

34.3

u/l

0.14

504

2752

(3011985) Renin [Units/volume] in Plasma

517

2859

1.73

29.66

1.7

1.4

63.5

58.0

mu/l

0.29

454

2542

(3034891) Synovial lining cells/100 cells in Synovial fluid

235

999

2.24

29.08

1.6

1.5

3.2

3.9

0.44

223

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

204

817

2.38

28.99

1.8

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

204

817

2.38

28.99

1.8

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

471

2556

1.76

28.89

1.2

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

744

4547

1.57

28.76

1.6

1.4

19.7

32.6

e6/l

1.26

586

3515

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

744

4552

1.56

28.62

1.6

1.4

1471.3

2451.2

e6/l

0.39

614

3710

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

332

1619

1.96

28.59

1.3

1.2

41.8

46.6

u/ml

0.15

135

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

331

1613

1.96

28.56

1.3

1.2

73.3

73.5

u/ml

0.00

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

156

554

2.68

28.52

1.4

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1471

18677

0.73

28.38

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

480

2633

1.74

28.37

1.5

30.8

33.1

g/l

3.31

415

2367

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

205

831

2.35

28.36

1.9

2.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

131

4.71

28.10

4.6

4.3

2.3

2.2

mg/l

0.16

108

(3026470) Cobalt [Mass/volume] in Blood

270

1235

2.08

27.79

2.1

1.9

4.5

3.7

ug/l

0.46

244

1080

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

215

898

2.28

27.77

2.4

—

(21494755) Public health laboratory ask at order entry panel

1592

19893

0.74

27.56

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

316

1536

1.96

27.49

1.6

1.5

26.3

24.2

u/ml

0.29

320

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

317

1544

1.96

27.42

1.3

1.2

9.7

10.3

u/ml

0.03

109

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

277

1287

2.05

27.35

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

222

950

2.23

27.08

3.7

3.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

556

3218

1.65

26.94

1.5

1.3

—

(3017569) Oxygen content in Arterial blood

211

887

2.27

26.86

2.4

2.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

325

1612

1.92

26.66

2.0

2.3

18.5

19.1

nmol/l

0.43

296

1535

(3023199) Leukocytes [#/volume] in Pleural fluid

434

2364

1.75

26.33

1.5

2735.4

2836.9

e6/l

0.06

322

1681

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

577

3391

1.63

26.32

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

162

611

2.52

26.27

1.7

1.4

—

(4035726)

2508

19097

1.27

26.18

1.5

1.4

—

(3019977) pH of Arterial blood

245

1106

2.11

26.14

2.9

2.4

7.4

0.05

389

(3025549) Creatine [Moles/time] in 24 hour Urine

155

4.23

26.10

1.6

1.3

—

14.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

376

1977

1.81

25.72

1.4

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

694

4284

1.55

25.70

1.5

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

21709

198207

1.17

25.45

25.1

14.7

38.6

39.7

50.54

14485

142899

(4306422)

527

3061

1.64

25.21

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

153

573

2.54

25.20

2.7

2.1

383.0

429.9

e6/l

0.07

313

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

219

963

2.17

25.02

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

219

963

2.17

25.02

1.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

108

340

3.02

24.71

1.1

2.4

8.5

pmol/l

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

330

1690

1.86

24.59

1.5

1.4

1.3

promille

0.09

256

1258

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

256

1203

2.03

24.57

2.8

2.2

101.1

97.3

0.88

239

1121

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

316

1597

1.89

24.54

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

478

2730

1.67

24.43

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

211

924

2.17

24.37

1.1

10.9

15.6

u/ml

0.25

(3016650) Hepatitis A virus Ab [Presence] in Serum

563

3353

1.60

24.36

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

22737

208564

1.18

24.31

4.9

4.5

6.0

5.9

mmol/l

5.14

20613

190224

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

255

1203

2.02

24.22

1.5

5.3

5.9

u/l

1.20

214

1023

(4268621)

384

2071

1.77

24.15

2.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

316

1606

1.88

24.12

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

416

2297

1.73

24.09

4.4

3.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

316

1608

1.87

24.03

1.2

—

(40768443) Skin Pathology biopsy report

1360

9642

1.35

23.93

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

314

1597

1.87

23.92

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

201

870

2.20

23.91

2.3

1.8

2.0

1.9

umol/l

0.21

189

813

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

315

1606

1.87

23.82

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

450

2547

1.69

23.81

1.1

—

(3045788) Cell count panel - Pleural fluid

345

1811

1.82

23.77

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

313

1595

1.87

23.71

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

245

1150

2.03

23.61

1.3

208.0

353.2

u/l

2.43

234

1055

(21494434) Karyotype in Bone marrow

331

1724

1.83

23.40

1.2

—

(3002619) Bacteria identified in Specimen by Culture

122

424

2.74

23.35

1.5

1.2

—

(3025315) Body weight

157

3.99

23.19

5.1

4.5

—

(3048879) Bone marrow aspiration report

149

574

2.47

23.17

1.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

500

2929

1.63

23.17

1.1

123.2

118.2

2.67

455

2618

(3045716) Anion gap in Serum or Plasma

202

888

2.17

23.14

2.8

2.5

9.1

9.2

mmol/l

0.07

151

645

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

249

1185

2.00

23.10

1.1

ratio

0.13

412

(3049717) Cytology report of Urine Cyto stain

1082

7439

1.39

23.04

2.4

2.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

430

2431

1.69

22.87

23.9

7.3

7.7

7.4

mmol/l

0.28

367

1982

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

267

3.20

22.79

2.0

1.9

—

(3045414) Leukocytes [Presence] in Urine

1366

9765

1.34

22.76

2.1

1.9

—

(3051651) Icteric interference index of Serum or Plasma

265

1296

1.95

22.75

4.9

3.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

129

468

2.62

22.72

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

690

4373

1.51

22.66

1.3

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

172

715

2.29

22.58

1.3

1.2

0.3

g/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

513

3051

1.61

22.36

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

515

3068

1.60

22.30

1.3

2.2

1.5

nmol/l

0.17

499

2944

(3008536) Aspergillus sp Ab [Presence] in Serum

115

398

2.75

22.21

2.3

2.2

—

(3045424) Erythrocytes [Presence] in Urine

594

3662

1.55

22.18

1.5

—

(3028433) Virus identified in Specimen by Culture

169

704

2.28

22.09

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

102

334

2.90

21.83

1.7

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

457

2661

1.64

21.72

1.3

299.6

300.1

pmol/l

0.01

341

2084

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

400

2252

1.69

21.64

1.8

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

203

921

2.10

21.49

2.6

1.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

287

1471

1.86

21.41

1.3

1.0

1.3

u/ml

0.24

158

665

(44816559) Phosphatidylethanol [Mass/volume] in Blood

608

3799

1.53

21.37

1.5

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

189

837

2.15

21.30

2.4

1.8

27.7

29.4

umol/l

1.22

181

806

(3018851) Theophylline [Moles/volume] in Serum or Plasma

168

3.73

21.15

1.9

1.7

55.3

44.5

umol/l

1.31

168

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

262

1312

1.90

21.01

1.4

1.3

110.5

58.7

titre

0.35

116

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

961

12452

0.72

20.98

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

213

3.35

20.42

1.4

1.2

5.6

6.5

mmol/l

0.54

107

(3022621) pH of Urine by Test strip

1890

14326

1.27

20.34

4.0

3.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

287

1496

1.83

20.31

1.9

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

507

3082

1.57

20.19

1.3

0.2

nmol/l

0.19

198

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

272

1399

1.85

20.10

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

265

1352

1.87

20.09

1.4

1.3

314.7

418.8

titre

0.31

104

(3028308) Erythrocytes [#/volume] in Pleural fluid

380

2154

1.68

20.08

1.5

64829.7

47818.6

e6/l

0.40

232

1247

(3012441) Differential panel - Pleural fluid

362

2031

1.70

19.88

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

272

1411

1.84

19.58

1.2

—

(3024263) Appearance of Synovial fluid

222

1085

1.95

19.19

1.9

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

19741

180096

1.13

19.15

29.1

16.5

14.0

13.7

120.39

19466

176166

(4034850)

993

6950

1.37

19.00

13.4

9.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

210

1011

1.98

18.97

1.9

1.5

19.8

25.6

umol/l

2.35

199

957

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

463

2803

1.58

18.81

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

130

520

2.38

18.73

1.7

169.6

133.1

au/ml

0.23

(3028707) Methadone [Presence] in Urine by Screen method

532

3327

1.53

18.69

3.7

2.6

—

(40768806) Pleura Pathology biopsy report

358

2038

1.67

18.66

1.6

1.5

—

(40761536) Microorganisms panel - Urine sediment

2338

18338

1.23

18.50

5.8

3.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

285

1530

1.77

18.35

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

108

404

2.54

17.99

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

144

616

2.22

17.78

3.2

3.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

228

1158

1.87

17.60

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

219

1098

1.90

17.59

1.9

1.4

13.0

7.7

ug/l

1.47

200

998

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

317

2.73

17.47

1.4

1.2

78.3

378.3

ng/l

0.58

202

(3022493) Free Hemoglobin [Mass/volume] in Plasma

183

865

2.01

17.45

2.7

5.2

70.4

1996.2

mg/l

2.32

134

616

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

372

2177

1.63

17.44

1.1

94.4

95.5

0.35

347

2028

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

318

1787

1.70

17.43

1.3

325.6

471.4

u/l

2.01

296

1694

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

204

1006

1.93

17.23

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

264

1420

1.77

16.93

1.6

1.4

13.0

12.8

u/l

0.16

255

1368

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

166

767

2.06

16.86

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

151

674

2.13

16.80

1.1

—

(3011648) Oxygen content in Venous blood

286

1581

1.72

16.67

4.4

2.4

10.9

11.0

0.06

286

1581

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

809

5598

1.38

16.66

1.8

1.7

42.2

40.8

nmol/l

0.94

780

5453

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

123

507

2.31

16.62

1.6

1.3

37.6

37.9

0.03

325

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

311

2.69

16.46

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

159

731

2.07

16.39

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

111

443

2.38

16.15

1.4

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

319

1834

1.66

16.09

1.4

1.3

6.6

6.4

mmol/l

0.69

291

1688

(3013166) Neutrophils/100 leukocytes in Synovial fluid

141

624

2.15

16.06

1.4

53.6

56.2

0.36

119

531

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

157

725

2.06

16.00

1.4

15.2

15.4

pmol/l

0.21

126

605

(3052592) Norovirus Ag [Presence] in Stool

104

407

2.43

15.81

1.4

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

761

5264

1.38

15.73

1.8

18.5

11.9

iu/l

0.20

238

1881

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

302

1730

1.66

15.46

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.27

15.45

10.7

11.4

208.8

297.3

e6/l

0.27

(4015189)

127

548

2.20

15.43

2.5

2.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

154

3.39

15.41

2.4

2.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

243

2.85

15.31

1.3

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

143

649

2.09

15.29

2.1

2.0

8.3

9.4

mg/l

1.44

119

527

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

174

3.22

15.23

1.1

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

473

3020

1.49

15.15

4.6

5.1

348.7

366.8

umol/l

1.90

406

2604

(3002621) Streptococcal DNAse B [Units/volume] in Serum

190

3.10

15.03

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

214

1122

1.81

15.02

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

105

423

2.36

15.00

1.5

1.4

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

222

1180

1.79

14.89

2.7

26.2

31.2

ug/l

—

(3000012) Reticulocyte production index

216

1139

1.80

14.88

1.4

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

639

4338

1.41

14.79

2.9

3.3

499.1

888.1

u/ml

0.78

574

3959

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

587

3929

1.43

14.72

2.0

1.9

186.7

196.5

pmol/l

1.68

560

3726

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

144

666

2.06

14.67

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1087

8016

1.30

14.57

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1415

10785

1.26

14.52

1.3

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

105

432

2.31

14.32

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

444

2836

1.49

14.23

1.1

1.6

1.5

g/l

1.62

392

2560

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

111

469

2.25

14.23

1.2

—

(3004451) EKG impression Narrative

194

1009

1.83

14.01

1.3

1.2

—

(3035880) pH of Pleural fluid

201

1058

1.81

13.96

1.4

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

228

1250

1.74

13.79

3.0

3.3

22.7

28.0

mu/l

1.64

216

1170

(3016018) Differential panel - Cerebral spinal fluid

367

2267

1.54

13.79

1.6

1.4

—

(4198724)

178

906

1.87

13.78

3.9

2.1

—

(40768441) Liver Pathology biopsy report

265

1514

1.67

13.77

1.6

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

318

2.51

13.77

1.3

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

384

2398

1.53

13.72

3.6

3.2

7.6

8.8

nmol/l

0.19

363

2326

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

159

781

1.94

13.71

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

278

1611

1.64

13.68

1.2

1.3

2.0

2.1

mmol/l

0.58

258

1495

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

242

1354

1.70

13.61

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4495

38154

1.14

13.50

1.6

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

670

4659

1.37

13.47

4.4

3.1

1.5

1.6

mmol/l

0.72

660

4563

(3036071) Salmonella sp Ab [Titer] in Serum

131

605

2.06

13.44

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

240

1346

1.70

13.39

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

785

5602

1.34

13.34

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

113

3.61

13.29

4.7

4.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

246

1396

1.68

13.15

1.3

12.6

13.4

u/l

0.34

214

1287

(3002256) Pathology report gross observation

3368

28073

1.16

13.12

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.47

13.12

2.9

3.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

254

1455

1.66

13.10

1.5

1.4

13.5

12.3

umol/l

1.64

240

1384

(3032352) Blasts [#/volume] in Cerebral spinal fluid

186

2.96

13.07

2.9

2.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

254

1458

1.66

13.00

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

101

428

2.24

12.90

1.4

1.3

67.3

82.9

mu/l

0.30

308

(3051593) INR in Capillary blood by Coagulation assay

186

982

1.80

12.84

10.3

10.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

605

2.03

12.72

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

828

5997

1.32

12.72

1.3

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

407

2626

1.48

12.47

3.1

2.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

294

2.49

12.44

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1031

7711

1.28

12.42

2.8

3.4

449.6

1519.8

u/ml

1.84

868

6552

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

152

3.12

12.36

1.6

1.8

2.0

mg/l

0.10

104

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

378

2408

1.50

12.35

1.9

1.8

3610.0

2200.4

titre

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

600

4159

1.38

12.34

4.2

1.8

0.9

0.8

nmol/l

0.51

482

3488

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

704

5003

1.34

12.34

2.6

2.3

153.5

104.6

ug/min

1.74

415

2929

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

159

3.05

12.09

5.6

5.8

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

160

3.03

11.97

1.4

1.2

16.1

15.0

nmol/l

—

(3000492) Spirometry study

2497

20483

1.17

11.95

1.6

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

920

6823

1.29

11.87

1.8

1.7

311.0

315.9

mu/l

0.14

852

6185

(40757494) Bilirubin.total [Moles/volume] in Blood

203

1126

1.71

11.86

2.5

2.1

16.2

27.9

umol/l

1.32

114

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.70

11.86

4.1

3.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.31

11.80

2.9

3.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

110

501

2.09

11.78

1.2

342.0

300.3

pmol/l

0.27

355

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

204

1136

1.71

11.75

1.3

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

919

6825

1.29

11.73

2.4

2.3

4595.8

5727.7

u/l

0.58

320

2646

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

443

2941

1.44

11.73

1.5

1.3

28.9

28.8

u/l

0.02

361

2404

(3026692) Albumin [Mass/volume] in Peritoneal fluid

110

502

2.08

11.72

1.8

1.4

11.7

13.9

g/l

1.74

390

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

244

1427

1.63

11.66

3.4

3.3

158.5

135.8

nmol/l

0.31

238

1409

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

487

3294

1.41

11.62

1.2

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

148

3.08

11.61

1.5

1.6

1.8

2.3

mg/l

0.31

112

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

148

3.08

11.61

1.5

1.6

mg/l

0.03

109

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

148

3.08

11.61

1.5

1.6

2.3

2.7

mg/l

0.16

100

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

148

3.08

11.61

1.5

1.6

2.5

2.8

mg/l

0.12

107

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

148

3.08

11.61

1.5

1.6

1.0

mg/l

0.51

103

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

148

3.08

11.61

1.5

1.6

0.9

1.1

mg/l

0.12

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

148

3.08

11.61

1.5

1.6

2.0

mg/l

0.17

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

148

3.08

11.61

1.5

1.6

2.3

4.1

mg/l

1.39

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

148

3.08

11.61

1.5

1.6

1.7

1.9

mg/l

0.10

101

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

237

2.60

11.57

1.4

1.3

62.7

214.0

u/l

0.60

171

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

129

3.24

11.56

3.3

2.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

288

2.44

11.52

1.2

1.4

8.0

241956.6

nmol/l

1.67

236

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

433

2873

1.44

11.51

2.6

2.7

2028.5

676.7

u/ml

0.41

422

2767

(3009871) Measles virus Ab [Titer] in Serum

137

681

1.91

11.49

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

167

2.90

11.13

1.3

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

215

2.65

11.08

2.0

2.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

106

492

2.05

10.83

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

303

2.35

10.78

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

261

1583

1.57

10.76

1.0

1.1

260.4

265.2

mg/l

0.12

217

1401

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

434

2918

1.42

10.75

1.1

4.5

3.3

u/ml

0.33

130

1371

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

125

617

1.93

10.74

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

219

2.60

10.69

1.5

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

269

1647

1.55

10.64

1.1

1.2

38.0

42.0

mg/l

0.85

217

1381

(3011288) Drugs identified in Urine by Screen method

714

5198

1.31

10.64

3.5

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

124

614

1.92

10.57

3.0

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

124

614

1.92

10.57

3.0

2.4

—

(3038515) Glucose [Moles/volume] in Venous blood

618

4420

1.33

10.45

4.5

3.2

7.5

7.6

mmol/l

0.40

609

4338

(3043410) Blood group antigens tested for on Red Blood Cells

116

564

1.95

10.43

2.1

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

250

1514

1.57

10.39

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

5.24

10.36

10.5

8.9

36.7

46.3

0.68

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

259

1588

1.55

10.21

1.1

298.6

290.2

mg/l

0.77

223

1418

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1414

11193

1.21

10.19

1.1

—

(3003129) Base excess in Capillary blood by calculation

108

519

1.98

10.06

1.9

1.7

1.1

0.6

mmol/l

0.60

101

487

(42529582) MDA5 Ab [Presence] in Serum by Line blot

105

502

1.99

9.93

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

105

502

1.99

9.93

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

105

502

1.99

9.93

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

105

502

1.99

9.93

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

117

581

1.91

9.92

1.6

9.7

9.0

ug/l

0.79

117

581

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.64

9.92

9.7

8.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

557

3958

1.34

9.87

1.6

—

(40762814) Titanium [Mass/volume] in Blood

358

2.18

9.86

2.4

2.2

3.1

3.7

ug/l

1.03

128

(43055442) Apixaban [Mass/volume] in Serum or Plasma

280

2.34

9.86

1.7

1.5

112.5

115.8

ug/l

0.08

229

(40761539) Cells [Type] in Urine sediment by Light microscopy

108

523

1.96

9.86

1.4

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

133

690

1.83

9.85

2.6

2.7

165.3

158.5

au/ml

0.05

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

141

751

1.78

9.59

3.3

8.5

7.9

mg/l

0.41

112

596

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

226

2.48

9.57

1.5

1.4

74.7

71.6

0.35

186

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.59

9.57

1.5

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

189

1093

1.64

9.55

1.1

u/l

0.18

494

(3041918) Cholesterol [Moles/volume] in Pleural fluid

357

2.15

9.53

1.4

1.2

1.6

1.7

mmol/l

0.29

216

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

172

971

1.68

9.53

2.3

1.9

154.9

144.3

0.85

157

905

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

131

684

1.82

9.52

1.2

111.8

107.8

0.51

119

618

(3042010) Triglyceride [Moles/volume] in Pleural fluid

279

2.31

9.50

1.5

1.2

0.9

1.5

mmol/l

0.65

181

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

162

2.75

9.40

1.3

1.2

ml/s/173m2

0.03

107

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

246

2.39

9.34

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

161

898

1.70

9.34

1.0

1.1

98.9

97.0

0.32

130

698

(3019174) dRVVT (LA screen)

169

2.70

9.23

1.3

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

237

2.40

9.14

10.3

8.7

0.4

umol/l

0.10

216

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

171

976

1.67

9.11

3.5

3.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

293

2.24

8.92

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

199

1191

1.59

8.79

2.1

1.8

2.4

2.6

u/field

0.10

142

833

(3006462) Nitrate [Presence] in Urine

177

1030

1.63

8.77

4.5

3.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.23

8.71

1.5

1.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

115

596

1.83

8.61

1.4

1.3

3.2

3.4

mmol/l

0.25

106

546

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.12

8.59

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

113

3.02

8.54

1.2

1.1

43.7

64.6

u/l

0.75

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

307

2027

1.44

8.52

1.4

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

124

660

1.78

8.52

1.1

95.3

89.2

0.91

290

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

198

1193

1.58

8.51

1.0

1.1

3.4

6.2

nmol/l

0.57

241

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

246

2.32

8.44

2.0

—

(3023410) Appearance of Cerebral spinal fluid

317

2116

1.43

8.30

1.9

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

141

2.76

8.28

1.2

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

346

2350

1.40

8.22

4.3

3.7

59.1

48.4

u/ml

0.36

334

2321

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

101

512

1.87

8.13

1.6

1.2

119.6

133.1

nmol/l

0.33

364

(1001926) Buprenorphine [Presence] in Urine by Screen method

788

6022

1.25

8.06

3.1

2.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

182

2.50

8.02

1.2

—

(3003694) ABO and Rh group [Type] in Blood

6666

59224

1.09

7.96

1.5

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

172

2.54

7.91

1.3

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

315

2.11

7.89

1.5

—

(4027681)

203

1255

1.54

7.84

1.2

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

143

813

1.67

7.81

2.7

2.4

—

(3005570) Glucose [Moles/volume] in Urine

330

2247

1.40

7.75

2.3

1.9

—

0.9

—

(3036180) Methadone [Presence] in Urine

5.47

7.74

1.5

2.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

694

8195

0.80

7.74

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

354

4566

0.73

7.72

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

425

3017

1.34

7.70

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

250

1625

1.46

7.59

3.2

2.4

—

(4211845)

185

1131

1.55

7.53

4.4

3.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.49

7.50

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

704

5359

1.25

7.48

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

312

2119

1.40

7.46

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

185

1134

1.55

7.45

1.5

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

144

2.64

7.44

1.3

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

272

1807

1.43

7.37

2.3

2.1

2.7

2.1

u/field

0.68

127

724

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

108

579

1.77

7.31

2.0

1.9

28.3

35.0

u/l

0.25

525

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

470

1.86

7.29

1.5

1.4

26.3

22.9

0.45

395

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

275

1835

1.43

7.28

1.5

1.3

1.5

1.4

nmol/l

0.95

245

1648

(3006576) Bicarbonate [Moles/volume] in Blood

127

714

1.69

7.27

7.0

6.2

24.6

25.1

mmol/l

0.78

116

647

(3045683) HLA typing for celiac disease panel - Blood or Tissue

199

1249

1.51

7.21

1.1

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.45

7.06

1.1

1.0

5.6

5.3

mmol/l

0.16

(3047352) Trisomy 18 risk [Likelihood] in Fetus

257

3436

0.71

7.04

1.5

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

128

728

1.67

7.03

1.2

0.3

g/l

0.34

103

593

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

206

2.30

7.03

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

474

3465

1.30

7.02

1.5

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

424

3053

1.32

7.01

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

265

3521

0.71

7.00

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

443

1.86

6.98

2.9

2.4

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

465

1.84

6.90

1.3

1.1

112.8

108.9

0.53

445

(40758292) HTLV I+II Ab panel - Serum

320

2.02

6.87

1.5

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

149

887

1.60

6.85

1.5

1.6

1772624.5

2268239.5

iu/ml

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

453

1.84

6.83

1.4

1.1

102.0

82.4

2.25

125

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

120

679

1.68

6.74

1.2

1.1

92.1

89.5

0.37

294

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

450

3286

1.30

6.74

1.1

15.2

11.4

au/ml

0.31

181

(3027923) C peptide [Moles/volume] in Serum or Plasma

180

1123

1.52

6.74

1.5

1.2

nmol/l

0.23

140

868

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1728

14399

1.15

6.73

1.2

128.6

145.7

iu/ml

0.96

628

5384

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

124

710

1.66

6.67

1.4

59.6

63.5

0.54

599

(4146454)

330

2308

1.36

6.66

2.8

2.7

—

(3005033) Fetal Nuchal fold Thickness US

259

3423

0.71

6.66

1.5

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

331

1.98

6.62

3.0

2.6

40.1

47.6

mg/l

0.17

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

337

4267

0.75

6.57

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

118

670

1.67

6.56

1.2

113.0

111.6

0.22

105

600

(3030313) Adrenal Ab [Titer] in Serum

177

2.36

6.55

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

337

4263

0.75

6.53

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

335

4238

0.75

6.50

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

164

1012

1.54

6.48

1.3

1.2

67.1

64.7

0.10

120

(3034426) Prothrombin time (PT)

122

702

1.65

6.45

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

289

2.04

6.45

6.4

5.1

49.3

43.4

ug/min

0.37

222

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

337

4255

0.75

6.45

1.4

—

(3000330) Specific gravity of Urine by Test strip

1333

10942

1.16

6.40

4.8

3.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

353

2511

1.34

6.39

2.1

1.9

26.7

22.8

ug/l

0.22

339

2450

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

101

554

1.73

6.38

1.3

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

112

2.71

6.33

1.3

1.4

341.5

303.1

umol/24h

0.41

112

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

451

1.81

6.33

1.3

1.2

86.2

72.7

0.96

120

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

118

677

1.66

6.32

2.3

2.5

1.3

1.1

ug/l

0.35

109

640

(3033799) Differential panel - Peritoneal fluid

114

650

1.67

6.26

2.1

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

782

6144

1.21

6.24

1.3

215.0

219.2

miu/ml

0.10

282

2787

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

447

1.81

6.21

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

103

2.76

6.16

1.2

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

539

1.73

6.15

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

244

2.10

6.12

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

533

1.73

6.11

1.3

1.4

20.3

20.4

0.01

494

(3016750) Collection duration of Urine

185

1188

1.48

6.08

2.5

2.1

517.0

499.3

min

1.48

126

907

(3002331) Protein [Mass/volume] in Peritoneal fluid

457

1.79

6.08

1.6

1.4

21.2

30.7

g/l

2.05

349

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.60

5.98

3.0

3.5

—

(3012898) Urea [Moles/volume] in Urine

203

2.20

5.97

1.3

1.5

147.7

176.3

mmol/l

0.79

184

(3001893) Eosinophils/100 leukocytes in Pleural fluid

105

594

1.68

5.96

1.4

3.1

2.6

0.18

511

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

481

1.76

5.95

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1448

12030

1.15

5.92

3.1

3.5

49.4

59.8

u/ml

0.89

1385

11610

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

267

2.03

5.89

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

282

1966

1.36

5.87

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

147

907

1.54

5.86

2.4

54.9

54.2

umol/l

0.08

115

750

(3010370) Gastrin [Moles/volume] in Serum or Plasma

336

1.89

5.71

2.0

1.9

44.2

56.1

pmol/l

0.60

280

(3011436) Histone Ab [Units/volume] in Serum

453

1.76

5.68

1.1

—

24.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

141

870

1.54

5.64

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

126

758

1.58

5.63

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

903

7263

1.18

5.62

2.9

2.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

103

2.67

5.61

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

126

759

1.58

5.60

2.6

1.9

1325.2

2912.7

e6/l

0.62

508

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

387

1.82

5.55

2.1

1.9

15.6

16.5

umol/l

0.28

387

(3014051) Protein [Presence] in Urine by Test strip

636

4958

1.22

5.54

2.6

2.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

21818

203596

1.07

5.52

4.2

3.9

1.3

mmol/l

5.30

19823

186201

(3023323) Follitropin [Units/volume] in Serum or Plasma

1102

9023

1.16

5.52

1.5

1.4

27.2

29.3

iu/l

1.22

952

7728

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

236

2.05

5.47

1.5

2.5

0.6

1.3

mmol/l

2.85

163

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

496

3776

1.25

5.40

4.9

3.4

46.2

39.1

u/ml

0.33

484

3640

(4212803)

188

2.17

5.34

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2261

23610

0.90

5.33

1.6

1.7

—

(3042517) Benzodiazepines panel - Urine

226

2.06

5.32

3.0

2.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.85

5.24

1.6

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3226

33080

0.91

5.22

2.9

0.7

0.8

ug/l

0.69

2087

21355

(3017509) Phencyclidine [Presence] in Urine

215

2.07

5.22

1.3

1.6

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

165

1071

1.46

5.21

1.6

1.3

3.6

4.8

umol/l

4.79

144

987

(3006270) Folate [Moles/volume] in Blood

261

1835

1.35

5.20

1.2

331.2

360.1

nmol/l

1.39

209

1527

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

22721

212440

1.08

5.20

4.7

4.4

4.6

4.7

mmol/l

26.82

20871

196661

(3028300) Cannabinoids [Presence] in Urine

967

7877

1.17

5.19

2.8

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

959

7809

1.17

5.18

2.8

2.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

3.51

5.17

1.1

1.0

0.2

0.0

g/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

429

3231

1.26

5.15

1.1

68.6

3935.3

iu/ml

0.66

100

711

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

122

747

1.55

5.09

2.4

2.0

178.4

168.7

0.36

117

703

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

257

1.96

5.04

2.2

3.3

34.5

40.9

umol/l

1.19

219

(3029075) Extractable nuclear Ab panel - Serum

105

624

1.60

4.99

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

962

7860

1.17

4.99

2.6

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2328

20114

1.11

4.99

2.1

2.0

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

100

589

1.61

4.93

1.4

1.6

—

430.4

iu/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

144

1992

0.68

4.93

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

147

944

1.48

4.92

3.1

1.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

124

770

1.53

4.88

2.3

3.0

29.0

28.6

umol/l

0.13

588

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

326

2391

1.30

4.87

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

363

1.78

4.82

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

364

1.77

4.78

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

364

1.77

4.78

1.3

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

156

1020

1.45

4.78

4.9

5.6

42.9

3998.1

u/ml

0.60

184

(44786800) Granulocytes/100 leukocytes in Body fluid

249

1.94

4.77

1.4

1.3

26.5

24.5

0.15

192

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.45

4.76

1.3

1.6

150.5

418.9

nmol/l

1.46

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

149

2.23

4.68

1.6

1.2

46.8

46.4

mg/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

23120

216495

1.07

4.64

5.1

4.9

2.7

2.8

mmol/l

49.50

21130

199352

(3039443) Prostate specific Ag panel - Serum or Plasma

285

3505

0.77

4.64

1.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

110

674

1.55

4.62

2.6

1.8

4828.3

10702.5

e6/l

1.00

358

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

557

1.60

4.56

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

189

1292

1.39

4.55

1.1

—

(4024509)

295

2157

1.30

4.54

1.7

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

323

3895

0.78

4.51

1.4

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

959

10441

0.87

4.51

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

131

840

1.48

4.47

1.1

160.0

624.7

ng/l

1.35

200

(3035611) Eosinophils/100 leukocytes in Synovial fluid

140

2.24

4.46

1.5

1.8

1.2

0.5

0.52

108

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

551

1.59

4.30

1.1

—

(3001729) Color of Synovial fluid

168

2.09

4.25

1.5

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

414

1.67

4.24

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

157

1054

1.41

4.23

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

206

1448

1.35

4.21

1.8

1.5

61.1

70.2

umol/l

—

112

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

152

1016

1.42

4.20

1.1

5.5

8.5

u/ml

0.79

169

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

120

2.29

4.17

1.1

1.2

1.1

u/field

0.29

(3027944) Amphetamines [Presence] in Urine

935

7737

1.15

4.16

2.8

1.9

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

189

2.01

4.15

1.3

1.2

101.9

110.4

ug/l

0.16

120

(3004775) Volume in Urine collected for unspecified duration

230

1651

1.32

4.09

2.5

2.2

717.6

662.8

1.11

155

1134

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

479

1.61

4.01

1.4

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.51

4.01

1.3

1.1

1.2

u/field

0.26

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

162

1105

1.39

4.01

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

472

1.61

4.00

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

254

1855

1.30

4.00

1.1

—

73.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.62

3.99

22.1

11.6

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

4.31

3.98

2.9

3.0

1.8

2.4

ug/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

200

1416

1.34

3.93

1.8

—

(40768795) Lymph node Pathology biopsy report

290

2161

1.28

3.92

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

490

1.59

3.90

1.7

1.2

16.2

16.9

umol/l

0.69

430

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

22500

210770

1.06

3.89

4.7

4.3

1.5

mmol/l

1.28

20565

194133

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4576

45803

0.94

3.89

4.2

4.1

21.7

21.9

0.35

2023

21520

(3035933) Granulocytes/100 leukocytes in Blood

551

1.55

3.87

2.2

1.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

144

2.11

3.80

1.5

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

473

5366

0.83

3.77

1.4

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.60

3.76

1.1

1.0

1.4

u/field

0.37

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

126

2.18

3.75

1.1

1.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.56

3.75

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

309

1.72

3.64

1.1

1.2

1.1

5.1

u/ml

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.49

3.63

1.0

1.1

143.9

241.1

pmol/l

1.00

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

561

1.52

3.60

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

375

1.65

3.59

1.2

1.4

68.0

201.1

titre

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

221

1.85

3.55

3.6

3.1

1.9

1.1

mg/l

0.74

155

(3034274) Bile acid [Moles/volume] in Serum --fasting

315

2402

1.25

3.54

2.3

2.1

9.4

7.5

umol/l

0.58

235

1762

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

117

2.19

3.53

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

175

1.95

3.50

2.6

2.2

62.5

58.0

0.22

111

(36303858) Crystals [Presence] in Urine

3.60

3.49

1.2

—

(44813793)

213

1551

1.30

3.49

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2521

22237

1.08

3.47

2.2

2.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

663

7257

0.86

3.45

1.4

—

(40765096) Chromosome analysis panel by Banding

575

1.50

3.43

1.2

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

7.38

3.42

2.7

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

138

944

1.39

3.42

1.1

1598.5

1528.1

miu/ml

0.34

138

944

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

9.48

3.38

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

577

4687

1.17

3.36

5.2

3.3

25.8

26.6

mg/l

0.26

367

2966

(3026726) Creatinine [Moles/volume] in Specimen

158

1.98

3.36

4.1

2.3

246.8

386.4

umol/l

0.63

150

(3019832) Treponema pallidum Ab [Presence] in Serum

2058

18033

1.09

3.34

1.7

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.48

3.34

1.1

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

526

1.52

3.32

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

101

657

1.46

3.32

1.4

1.2

26.4

19.5

0.34

101

(3013336) Amino acids [Identifier] in Serum or Plasma

2.95

3.31

1.6

2.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

565

1.50

3.30

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

234

1.78

3.28

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

490

1.53

3.27

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

605

1.47

3.26

2.4

1.9

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

147

2.00

3.25

1.4

1.5

38.4

37.5

0.04

(3049242) von Willebrand panel - Platelet poor plasma

2.60

3.22

1.3

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

372

1.61

3.22

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

170

1215

1.33

3.21

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

503

1.51

3.12

10.6

8.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

146

1025

1.35

3.12

2.1

113.1

103.8

ug/min

0.07

228

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

866

7284

1.13

3.12

2.0

1.8

—

(3024316) Viscosity of Plasma

2.24

3.08

1.3

1.7

1.6

mpas

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

296

1.67

3.08

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

225

1.77

3.08

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

366

2883

1.21

3.07

1.7

1.4

0.3

0.4

nmol/l

4.27

280

2192

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

452

1.53

3.07

7.4

5.8

66.1

69.3

0.41

349

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

309

3570

0.82

3.06

1.8

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

5.06

3.05

1.5

1.6

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

5.06

3.05

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

569

4658

1.16

3.04

2.1

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

253

2981

0.80

3.03

1.4

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

679

5636

1.15

3.00

6.0

4.2

—

(3028717) Thiamine [Mass/volume] in Blood

213

1.78

3.00

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

570

1.47

2.99

1.1

3.8

10.1

u/ml

0.47

309

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

277

1.68

2.99

1.3

1.4

42.1

54.1

1.10

137

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

139

1.98

2.98

2.6

2.2

13.7

18.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

299

1.65

2.98

1.1

—

(40768800) Prostate Pathology biopsy report

299

3453

0.82

2.97

1.2

—

(40760512) CD34 cells/100 cells in Bone marrow

7.11

2.94

1.8

1.9

—

(44806071)

264

1.69

2.94

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

345

1.60

2.91

1.4

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6204

56616

1.05

2.90

1.7

1.6

1.4

mmol/l

3.52

5301

47464

(3007916) DNA double strand Ab [Titer] in Serum

267

1.67

2.83

1.7

1.2

104.3

213.6

titre

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

183

1349

1.29

2.82

1.1

10.8

8.3

iu/ml

0.58

308

(3013139) Helicobacter pylori Ag [Presence] in Stool

1679

14705

1.09

2.80

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.41

2.79

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

967

0.68

2.72

1.2

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

474

1.48

2.70

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

200

1.76

2.67

3.8

3.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

295

1.61

2.63

1.4

9.0

12.3

0.55

157

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

273

1.63

2.63

2.8

2.5

0.5

0.7

u/field

0.81

273

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

237

1.68

2.62

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.78

2.59

1.5

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

134

1.91

2.55

1.3

1.4

18.1

18.3

pmol/l

0.02

113

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.90

2.55

2.6

4.9

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.10

2.54

1.0

0.2

0.1

u/ml

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

128

1.93

2.52

1.1

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

498

1.45

2.50

1.4

1.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.33

2.48

1.2

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

143

1.86

2.45

1.4

1.3

21.6

21.9

mmol/l

0.09

103

(3038071) Oxygen [Partial pressure] in Mixed venous blood

438

1.47

2.44

11.6

7.9

—

(37019676) Renin [Units/volume] in Plasma --supine

2.46

2.42

1.0

1.1

9.9

77.8

mu/l

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

173

1.75

2.35

1.1

4.6

18.0

iu/ml

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.06

2.34

1.6

1.2

0.1

g/l

0.17

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

396

1.49

2.34

4.0

5.1

35.0

56.1

u/l

1.12

153

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

125

1.90

2.34

1.3

1.8

202.2

186.5

ug/g

0.14

107

(3020123) Porphyrins [Interpretation] in Serum or Plasma

127

1.87

2.24

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

937

0.71

2.22

2.2

1.8

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.26

2.19

1.1

1.2

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.00

2.17

1.1

8.5

8.7

0.05

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.00

2.17

1.1

21.4

21.3

0.04

(3013247) Albumin in CSF/Albumin in Serum or Plasma

451

1.43

2.15

1.1

6.7

7.1

mg/g

0.17

430

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

164

1.74

2.14

2.9

2.7

168.5

58.7

pmol/l

0.29

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

150

1.77

2.14

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

222

1.62

2.13

1.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.69

2.13

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

123

1.85

2.11

4.5

3.6

5.7

13.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

117

1.86

2.07

1.5

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

166

1.71

2.07

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.96

2.06

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.85

2.01

1.3

1.7

1.9

2.1

mmol/24h

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.74

1.98

1.0

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

435

1.42

1.98

1.2

0.9

42.1

mg/l

1.43

327

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.03

1.97

1.0

—

(3020491) Glucose [Moles/volume] in Blood

205

1607

1.21

1.95

1.8

7.3

6.8

mmol/l

1.08

145

1147

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.99

1.94

1.1

1.0

0.2

0.1

u/ml

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1084

0.75

1.91

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

164

1263

1.23

1.87

1.6

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1122

9852

1.08

1.87

2.0

1.8

—

(40768793) Breast Pathology biopsy report

610

5205

1.11

1.87

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.02

1.83

1.3

1.4

497.7

498.9

nmol/l

0.00

(3014891) Appearance of Pleural fluid

270

1.51

1.82

1.7

1.6

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.81

1.81

1.3

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1393

12359

1.07

1.78

2.2

1.9

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

272

1.50

1.77

15.4

8.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

265

1.50

1.75

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

153

1.67

1.75

4.1

4.9

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

281

1.49

1.74

2.9

2.6

62.1

76.8

pmol/l

0.46

245

(3036005) Urine sediment comments by Light microscopy Narrative

3.35

1.74

1.2

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

258

1.51

1.74

1.0

1.1

0.3

u/ml

0.05

161

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

132

1.72

1.73

1.0

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.43

1.72

2.0

2.4

1.5

2.7

mu/l

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.32

1.72

5.4

5.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

117

877

1.27

1.72

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

415

3483

1.13

1.71

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.19

1.66

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.90

1.65

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

616

1.31

1.63

1.1

6.9

10.1

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

422

3562

1.13

1.61

1.1

6.0

5.3

u/ml

0.32

227

1813

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.53

1.61

1.0

1.2

1.5

1.8

mg/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.53

1.61

1.1

1.2

76.8

92.2

nmol/24h

—

(3007147) Virus identified in Stool by Electron microscopy

3.39

1.53

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.80

1.50

1.0

1.1

0.1

0.5

u/ml

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

138

1.65

1.50

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

469

4004

1.11

1.49

1.1

1.4

1.7

u/ml

0.33

205

1620

(3003338) MCHC [Mass/volume]

19624

184431

1.03

1.49

30.8

17.6

331.1

332.3

g/l

61.34

19486

182925

(3032641) Amino acids panel - Urine

2.84

1.49

1.5

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.07

1.47

1.4

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

103

1.75

1.46

1.2

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

246

1.47

1.45

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

173

1383

1.19

1.43

1.0

764.2

729.5

ng/l

0.45

111

940

(3007463) Buprenorphine [Presence] in Urine

1.87

1.42

6.9

6.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.03

1.41

2.3

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

119

1.67

1.40

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

173

1386

1.18

1.40

1.0

38.4

43.9

ng/l

1.06

115

956

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

106

809

1.24

1.40

1.9

—

(3027874) Urate [Moles/volume] in Urine

1.96

1.39

1.1

1.0

0.6

1.8

mmol/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

172

1378

1.18

1.39

1.0

312.6

344.6

ng/l

0.44

117

969

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

296

1.41

1.39

1.3

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.09

1.38

1.4

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

142

1.60

1.37

1.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

485

1.31

1.35

1.1

27.1

0.8

umol/24h

0.49

234

(3010937) Rubella virus Ab [Presence] in Serum

106

1.70

1.34

1.2

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

347

1.37

1.33

2.8

2.7

2220.0

1840.0

u/l

0.11

317

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

389

1.34

1.30

2.1

2.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

167

1.53

1.29

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

175

1.52

1.28

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.80

1.28

1.5

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

242

2011

1.14

1.25

5.1

4.8

86.9

108.9

u/ml

0.21

615

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.78

1.24

1.1

7723.3

4074.0

ng/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

113

0.42

1.24

1.2

1.1

7.4

8.3

mmol/l

—

113

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

296

1.38

1.22

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

110

1.64

1.20

1.2

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

153

1234

1.18

1.19

1.1

0.5

2.1

u/ml

1.78

364

(46236302) HLA-C [Type] by High resolution typing

1.81

1.15

1.0

—

(40760410) HLA-B [Type] by High resolution

1.81

1.15

1.0

—

(40760409) HLA-A [Type] by High resolution

1.81

1.15

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.05

1.14

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

196

1.45

1.14

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

127

1.57

1.13

1.0

0.2

1.5

u/ml

0.72

(3051101) Glucose [Moles/volume] in Cord blood

393

0.70

1.13

4.8

5.8

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

293

1.36

1.12

1.0

68.0

81.0

ug/l

1.76

229

(3002523) Influenza virus A Ag [Presence] in Specimen

367

3156

1.10

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

367

3159

1.10

1.08

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

2.37

1.08

1.0

1.2

66.7

69.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.37

1.08

1.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

199

1.43

1.07

1.0

0.0

0.1

u/ml

1.87

120

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

115

1294

0.84

1.07

1.1

1.3

1.4

1.5

g/l

—

(3013862) HLA-DP [Type]

1.76

1.06

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

555

1.25

1.06

1.2

1.3

36.0

334.9

ug/l

2.95

302

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.81

1.06

1.2

1.1

—

(3001556) Androgen free Index in Serum or Plasma

184

1.44

1.05

1.7

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

395

3419

1.10

1.05

1.1

1.2

u/ml

0.06

180

1457

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

339

1.32

1.03

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

323

1.32

1.02

2.0

1.6

0.3

0.2

nmol/l

0.34

236

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

163

1345

1.15

0.99

7.1

6.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

682

0.79

0.99

1.6

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

203

1.40

0.98

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

188

1.41

0.96

1.1

—

(3015183) Erythrocyte sedimentation rate

125

1015

1.17

0.95

1.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

118

1.53

0.94

1.1

6.3

2.0

u/l

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.28

0.94

1.3

1.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

165

1.44

0.94

1.0

0.1

0.5

u/ml

0.98

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

111

1.54

0.92

1.1

1.2

—

10925.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

145

1198

1.15

0.90

10.8

12.0

0.6

mmol/l

0.37

135

1096

(3022670) pH of Venous cord blood

2.03

0.88

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.64

0.87

1.4

1.1

—

(40763590) HLA-DQ beta [Type]

1.67

0.85

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.90

0.82

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.90

0.82

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.90

0.82

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.90

0.82

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.90

0.82

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.90

0.82

2.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.68

0.80

1.0

1.1

—

mmol/l

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.84

0.79

1.0

1.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.56

0.78

1.0

1.1

0.0

0.7

u/ml

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

339

1.26

0.77

2.2

1.7

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

1.67

0.74

1.0

1.1

3.2

3.8

kpa

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.60

0.74

1.0

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.06

0.74

1.0

1.3

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

1.64

0.73

1.0

1.1

7.2

kpa

—

(3006598) pH of Arterial cord blood

1.64

0.73

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3629

35156

0.98

0.72

1.5

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

104

1133

0.87

0.72

1.1

—

(1002224) Polysomnography panel

865

8593

0.95

0.72

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

578

5174

1.06

0.72

1.4

122.5

155.4

pmol/l

2.16

559

5039

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.75

0.71

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

152

1.37

0.69

1.0

1.1

10.4

10.0

u/l

0.04

152

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

431

1.21

0.68

2.7

1.7

2.3

2.9

ug/l

0.35

249

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2112

19475

1.03

0.68

1.4

—

(4094501)

583

5838

0.95

0.67

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

120

1285

0.88

0.66

1.4

1.6

7.5

7.8

mmol/l

0.92

772

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

113

1.43

0.66

1.0

0.0

0.3

u/ml

2.78

101

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.58

0.64

1.0

1.1

3.4

2.5

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

196

1.31

0.63

1.1

1.0

0.3

1.1

u/ml

1.58

146

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

132

1119

1.12

0.62

1.3

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

257

1.25

0.60

1.3

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

173

1.32

0.60

1.7

1.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.53

0.59

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

632

1.16

0.59

1.3

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

721

6538

1.05

0.59

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

199

1.29

0.58

1.1

1.0

0.0

2.1

u/ml

2.09

146

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

251

1.25

0.56

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

109

1.39

0.56

1.3

1.5

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.63

0.55

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

370

3305

1.06

0.54

1.1

1.9

2.1

u/ml

0.17

837

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

487

1.17

0.54

3.0

2.8

140.3

118.8

ng/l

0.28

223

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

1.58

0.54

2.3

2.1

8.1

19.6

ng/l

—

(40758358) Immune stain study

102

1.39

0.53

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

185

1.28

0.53

1.0

0.6

2.7

u/ml

0.54

(3023430) Cat dander IgE Ab [Units/volume] in Serum

295

2619

1.07

0.53

1.0

1.1

4.7

5.0

u/ml

0.08

125

1085

(3025130) Human papilloma virus identified in Specimen

315

2803

1.07

0.53

1.9

1.7

—

(44806420)

609

0.86

0.52

2.2

2.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

186

1.27

0.51

2.3

2.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.54

0.48

2.1

2.2

—

(3000034) Microalbumin [Mass/volume] in Urine

223

1969

1.07

0.48

3.1

3.0

90.8

45.6

mg/l

0.91

162

1395

(3014133) Dog dander IgE Ab [Units/volume] in Serum

315

2816

1.06

0.48

1.1

4.2

4.7

u/ml

0.15

134

1116

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

180

1.26

0.47

1.0

1.7

1.1

u/ml

0.14

103

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

130

1.31

0.46

1.1

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

140

1216

1.09

0.46

1.0

1.1

0.5

4.6

u/ml

1.02

308

(3005011) Chlamydia sp Ab [Titer] in Serum

305

1.18

0.42

1.7

1.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

423

0.85

0.42

2.6

3.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

271

1.19

0.41

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

422

0.85

0.41

5.3

6.4

—

(3018291) Platelet Ab [Presence] in Serum

1.48

0.40

1.4

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.33

0.40

1.0

77.4

433.7

u/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

246

1.20

0.39

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

267

0.82

0.39

1.8

2.4

—

(3029612) Listeria sp Ab [Titer] in Serum

1.44

0.39

1.2

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

334

1.16

0.39

1.1

2.9

5.3

u/ml

0.46

238

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

143

1.26

0.38

1.1

71.0

32.1

u/ml

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.39

0.38

1.0

0.0

0.2

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

626

1.11

0.34

1.3

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

872

0.91

0.34

1.7

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

772

1.09

0.34

1.1

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

120

1.26

0.34

1.1

1.0

0.3

0.7

u/ml

0.96

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

138

1.24

0.32

1.1

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

276

2497

1.05

0.32

1.5

—

(4038314)

113

1.26

0.31

1.5

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.33

0.31

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

252

2280

1.05

0.30

1.5

1.4

3.4

4.0

ug/l

0.48

218

1968

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.25

0.29

1.0

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

132

1.22

0.28

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

149

1334

1.06

0.27

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

107

1.24

0.26

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

275

1.14

0.26

1.3

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

249

2266

1.04

0.25

1.0

1.1

1.3

0.5

u/ml

0.76

515

(4133840)

585

1.09

0.25

1.3

1.2

—

(3013762) Body weight Measured

1.20

0.25

1.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

668

1.08

0.24

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.17

0.24

1.1

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

734

0.93

0.22

2.2

2.4

148.8

150.4

nmol/l

0.05

633

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.24

0.22

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

168

1522

1.05

0.22

1.4

1.3

87.8

89.9

pmol/l

0.03

483

(3009677) Dengue virus Ab [Presence] in Serum

1.26

0.22

1.3

1.2

—

(3034614) HLA Ag [Interpretation]

1.19

0.21

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.79

0.21

10.0

8.9

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

111

1.20

0.20

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

129

1.18

0.20

1.1

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

301

1.10

0.19

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

539

1.07

0.19

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

236

0.88

0.18

1.1

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

199

1826

1.03

0.16

1.2

1.3

12.3

11.8

mmol/l

0.30

463

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

589

1.06

0.16

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

460

1.07

0.16

2.1

2.3

7.6

7.4

mmol/l

0.13

275

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.80

0.14

1.1

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

233

1.10

0.14

1.1

15.0

1.7

umol/24h

0.48

233

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

243

1.09

0.13

1.4

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

465

0.94

0.13

2.7

2.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

225

1.10

0.13

1.1

23.4

19.7

u/l

0.50

146

(3020650) Glucose [Presence] in Urine

552

0.94

0.13

1.5

—

(3022475) Manganese [Moles/volume] in Blood

134

1.13

0.13

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

116

1.14

0.13

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

102

0.84

0.13

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

116

1140

0.96

0.13

1.3

5.8

mmol/l

0.04

109

1075

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

140

0.88

0.12

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

294

2844

0.98

0.12

1.3

7.0

7.3

mmol/l

0.96

220

2046

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.10

0.09

1.2

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.05

0.09

2.0

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.03

0.09

3.0

1.4

0.2

0.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.09

0.09

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.80

0.08

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.80

0.08

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

185

0.92

0.08

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

186

1788

0.99

0.05

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6066

57434

1.00

0.04

5.0

4.7

3.7

3.1

ug/l

0.28

5362

51739

(3005082) Progesterone [Moles/volume] in Serum or Plasma

858

0.98

0.03

1.3

1.4

27.2

30.6

nmol/l

0.52

773

(3015076) Soybean IgE Ab [Units/volume] in Serum

112

1077

0.99

0.03

1.1

1.0

0.4

1.0

u/ml

0.64

155

(4281824)

264

2522

0.99

0.03

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

241

2300

0.99

0.02

1.2

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

342

1.03

0.02

6.3

7.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

154

1.05

0.02

1.1

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

184

0.98

0.00

6.9

7.7

—

(46235168) Fasting glucose [Moles/volume] in Blood

255

1.00

0.00

1.7

2.2

7.4

7.5

mmol/l

—

104

(3020356) Listeria sp identified in Specimen by Organism specific culture

106

0.98

0.00

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

106

0.98

0.00

1.2

1.0

8.1

20.8

u/ml

1.12

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

156

1.03

0.00

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

156

1.03

0.00

1.1

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

204

0.98

0.00

2.3

2.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

791

7503

1.00

0.00

1.9

1.7

5.1

3.4

mg/l

2.79

598

5264

(3033016) Trichoderma viride IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.2

—

4.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.6

—

(3029088) Stachybotrys chartarum IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.97

0.00

1.0

—

1.3

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3034610) Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3025311) HLA-B [Type]

0.00

0.0

1.0

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.96

0.00

2.3

1.1

976.7

371.8

pmol/l

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.2

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

8.8

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.0

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.00

0.00

1.1

221.9

267.1

nmol/l

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.0

6.5

—

139.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_OSTEOCHONDRO and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_OSTEOCHONDRO	1.802 [1.64, 1.98]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.049

During the follow-up period (1.1.1998 — 31.12.2019), 36202 out of 109937 females with M13_OSTEOCHONDRO died.

Males

Parameter	HR [95% CI]	p-value
M13_OSTEOCHONDRO	2.271 [2.03, 2.54]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 13676 out of 59070 males with M13_OSTEOCHONDRO died.

Mortality risk

Mortality risk for people of age

years, who have M13_OSTEOCHONDRO.

N-year risk	Females	Males
1	0.185%	0.472%
5	1.041%	2.637%
10	2.385%	6.006%
15	4.319%	11.435%
20	7.194%	19.301%

Relationships between endpoints

↥

Index endpoint: M13_OSTEOCHONDRO – Osteopathies and chondropathies

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Osteopathies and chondropathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints